1,418 results on '"Choi, Sk"'
Search Results
2. 3-aminopropyl functionalized magnesium phyllosilicate as an organoclay based drug carrier for improving the bioavailability of flurbiprofen
- Author
-
Yang L, Choi SK, Shin HJ, and Han HK
- Subjects
Medicine (General) ,R5-920 - Abstract
Liang Yang,1 Soo-Kyung Choi,2 Hyun-Jae Shin,2 Hyo-Kyung Han1 1College of Pharmacy, Dongguk University-Seoul, Siksa-dong, Ilsan-Donggu, Goyang, Gyunggi-do, Korea; 2Department of Chemical and Biochemical Engineering, Chosun University, Gwangju, Korea Abstract: This study aimed to develop an oral delivery system using clay-based organic–inorganic hybrid materials to improve the bioavailability of the drug, flurbiprofen, which is poorly soluble in water. 3-aminopropyl functionalized magnesium phyllosilicate (AMP clay) was synthesized by a one-pot direct sol-gel method, and then flurbiprofen (FB) was incorporated into AMP clay (FB-AMP) at different drug/clay ratios. The structural characteristics of AMP and FB-AMP formulation were confirmed by X-ray diffraction, Fourier transform infrared spectroscopy, and transmission electron microscopy. Among tested formulations, FB-AMP(3), dramatically increased the dissolution of FB and achieved rapid and complete drug release within 2 hours. More than 60% of FB was released from FB-AMP(3) after 30 minutes; the drug was completely dissolved in the water within 2 hours. Under the acidic condition (pH 1.2), FB-AMP(3) also increased the dissolution of FB by up to 47.1% within 1 hour, which was three-fold higher than that of untreated FB. Furthermore, following an oral administration of FB-AMP(3) to Sprague-Dawley rats, the peak plasma concentration and area under the plasma concentration-time curve of FB increased two-fold, and the time to reach the peak plasma concentration was shortened compared with that in the untreated FB. This result suggests that the oral drug delivery system using clay-based organic–inorganic hybrid material might be useful to improve the bioavailability of FB. Keywords: poorly water-soluble drugs, aminopropyl functionalized magnesium phyllosilicate, organic clay, oral bioavailability
- Published
- 2013
3. Measurement of e(+)e(-) -> pi(+)pi(-) D+D- cross sections at center-of-mass energies from 4.190 to 4.946 GeV
- Author
-
Ablikim, M, Achasov, Mn, Adlarson, P, Albrecht, M, Aliberti, R, Amoroso, A, Mr, An, An, Q, Bai, Xh, Bai, Y, Bakina, O, Ferroli, Rb, Balossino, I, Ban, Y, Batozskaya, V, Becker, D, Begzsuren, K, Berger, N, Bertani, M, Bettoni, D, Bianchi, F, Bloms, J, Bortone, A, Boyko, I, Briere, Ra, Brueggemann, A, Cai, H, Cai, X, Calcaterra, A, Cao, Gf, Cao, N, Cetin, Sa, Chang, Jf, Chang, Wl, Chelkov, G, Chen, C, Chen, G, Chen, Hs, Chen, Ml, Chen, Sj, Chen, Sm, Chen, T, Chen, Xr, Chen, Xt, Chen, Yb, Chen, Zj, Cheng, Ws, Choi, Sk, Chu, X, Cibinetto, G, Cossio, F, Cui, Jj, Dai, Hl, Dai, Jp, Dbeyssi, A, de Boer, Re, Dedovich, D, Deng, Zy, Denig, A, Denysenko, I, Destefanis, M, De Mori, F, Ding, Y, Dong, J, Dong, Ly, Dong, My, Dong, X, Sx, Du, Egorov, P, Fan, Yl, Fang, J, Fang, Ss, Fang, Wx, Fang, Y, Farinelli, R, Fava, L, Feldbauer, F, Felici, G, Feng, Cq, Feng, Jh, Fischer, K, Fritsch, M, Fritzsch, C, Cd, Fu, Gao, H, Gao, Yn, Gao, Y, Garbolino, S, Garzia, I, Pt, Ge, Zw, Ge, Geng, C, Gersabeck, Em, Gilman, A, Gong, L, Gong, Wx, Gradl, W, Greco, M, Lm, Gu, Mh, Gu, Yt, Gu, Guan, Cy, Guo, Aq, Guo, Lb, Guo, Rp, Guo, Yp, Guskov, A, Han, Tt, Han, Wy, Hao, Xq, Harris, Fa, Kk, He, Kl, He, Heinsius, Fh, Heinz, Ch, Heng, Yk, Herold, C, Himmelreich, M, Hou, Gy, Hou, Yr, Hou, Zl, Hm, Hu, Jf, Hu, Hu, T, Hu, Y, Huang, Gs, Huang, Kx, Huang, Lq, Huang, Xt, Huang, Yp, Huang, Z, Hussain, T, Husken, N, Imoehl, W, Irshad, M, Jackson, J, Jaeger, S, Janchiv, S, Jang, E, Jeong, Jh, Ji, Q, Qp, Ji, Xb, Ji, Xl, Ji, Yy, Ji, Jia, Zk, Jiang, Hb, Jiang, Ss, Jiang, Xs, Jiang, Y, Jiao, Jb, Jiao, Z, Jin, S, Jin, Y, Jing, Mq, Johansson, T, Kalantar-Nayestanaki, N, Kang, Xs, Kappert, R, Kavatsyuk, M, Bc, Ke, Keshk, Ik, Khoukaz, A, Kiese, P, Kiuchi, R, Koch, L, Kolcu, Ob, Kopf, B, Kuemmel, M, Kuessner, M, Kupsc, A, Kuhn, W, Lane, Jj, Lange, Js, Larin, P, Lavania, A, Lavezzi, L, Lei, Zh, Leithoff, H, Lellmann, M, Lenz, T, Li, C, Ch, Li, Dm, Li, Li, F, Li, G, Li, H, Hb, Li, Hj, Li, Hn, Li, Jq, Li, Js, Li, Jw, Li, Li, K, Lj, Li, Lk, Li, Li, L, Mh, Li, Pr, Li, Sx, Li, Sy, Li, Li, T, Wd, Li, Wg, Li, Xh, Li, Xl, Li, Xy, Li, Liang, H, Liang, Yf, Liang, Yt, Liao, Gr, Liao, Lz, Libby, J, Limphirat, A, Lin, Cx, Lin, Dx, Lin, T, Liu, Bj, Liu, Cx, Liu, D, Liu, Fh, Liu, F, Liu, Gm, Liu, H, Liu, Hb, Liu, Hm, Liu, Hh, Liu, Jb, Liu, Jl, Liu, Jy, Liu, K, Liu, Ky, Liu, L, Liu, Mh, Liu, Pl, Liu, Q, Liu, Sb, Liu, T, Liu, Wk, Liu, Wm, Liu, X, Liu, Y, Liu, Yb, Liu, Za, Liu, Zq, Lou, Xc, Fx, Lu, Hj, Lu, Jg, Lu, Xl, Lu, Lu, Y, Yp, Lu, Zh, Lu, Luo, Cl, Luo, Mx, Luo, T, Luo, Xl, Lyu, Xr, Lyu, Yf, Fc, Ma, Hl, Ma, Ll, Ma, Mm, Ma, Qm, Ma, Rq, Ma, Rt, Ma, Xy, Ma, Ma, Y, Maas, Fe, Maggiora, M, Maldaner, S, Malde, S, Malik, Qa, Mangoni, A, Mao, Yj, Mao, Zp, Marcello, S, Meng, Zx, Mezzadri, G, Miao, H, Min, Tj, Mitchell, Re, Xh, Mo, Muchnoi, Ny, Nefedov, Y, Nerling, F, Nikolaev, Ib, Ning, Z, Nisar, S, Niu, Y, Olsen, Sl, Ouyang, Q, Pacetti, S, Pan, X, Pan, Y, Pathak, A, Pelizaeus, M, Peng, Hp, Pettersson, J, Ping, Jl, Ping, Rg, Plura, S, Pogodin, S, Prasad, V, Fz, Qi, Qi, H, Hr, Qi, Qi, M, Ty, Qi, Qian, S, Qian, Wb, Qian, Z, Qiao, Cf, Qin, Jj, Qin, Lq, Qin, Xp, Qin, Xs, Qin, Zh, Qiu, Jf, Sq, Qu, Rashid, Kh, Redmer, Cf, Ren, Kj, Rivetti, A, Rodin, V, Rolo, M, Rong, G, Rosner, C, Ruan, Sn, Sang, Hs, Sarantsev, A, Schelhaas, Y, Schnier, C, Schoenning, K, Scodeggio, M, Shan, Ky, Shan, W, Shan, Xy, Shangguan, Jf, Shao, Lg, Shao, M, Shen, Cp, Shen, Hf, Shen, Xy, Shi, Ba, Shi, Hc, Shi, Jy, Shi, Qq, Shi, Rs, Shi, X, Shi, Xd, Song, Jj, Song, Wm, Song, Yx, Sosio, S, Spataro, S, Stieler, F, Kx, Su, Pp, Su, Yj, Su, Sun, Gx, Sun, H, Sun, Hk, Sun, Jf, Sun, L, Sun, Ss, Sun, T, Sun, Wy, Sun, X, Sun, Yj, Sun, Yz, Sun, Zt, Tan, Yh, Tan, Yx, Tang, Cj, Tang, Gy, Tang, J, Tao, Ly, Tao, Qt, Tat, M, Teng, Jx, Thoren, V, Tian, Wh, Tian, Y, Uman, I, Wang, B, Wang, Bl, Wang, Cw, Wang, Dy, Wang, F, Wang, Hj, Wang, Hp, Wang, K, Wang, Ll, Wang, M, Wang, Mz, Wang, S, Wang, T, Wang, Tj, Wang, W, Wang, Wh, Wang, Wp, Wang, X, Wang, Xf, Wang, Xl, Wang, Yd, Wang, Yf, Wang, Yh, Wang, Yq, Wang, Y, Wang, Z, Wang, Zy, Wei, Dh, Weidner, F, Wen, Sp, White, Dj, Wiedner, U, Wilkinson, G, Wolke, M, Wollenberg, L, Jf, Wu, Lh, Wu, Lj, Wu, Wu, X, Xh, Wu, Wu, Y, Wu, Z, Xia, L, Xiang, T, Xiao, D, Xiao, Gy, Xiao, H, Xiao, Sy, Xiao, Yl, Xiao, Zj, Xie, C, Xie, Xh, Xie, Y, Xie, Yg, Xie, Yh, Xie, Zp, Xing, Ty, Cf, Xu, Cj, Xu, Gf, Xu, Hy, Xu, Qj, Xu, Sy, Xu, Xp, Xu, Yc, Xu, Zp, Xu, Yan, F, Yan, L, Yan, Wb, Yan, Wc, Yang, Hj, Yang, Hl, Yang, Hx, Yang, L, Yang, Sl, Yang, T, Yang, Yf, Yang, Yx, Ye, M, Mh, Ye, Yin, Jh, You, Zy, Bx, Yu, Cx, Yu, Yu, G, Yu, T, Xd, Yu, Yuan, Cz, Yuan, L, Yuan, Sc, Yuan, Xq, Yuan, Y, Yuan, Zy, Yue, Cx, Zafar, Aa, Zeng, Fr, Zeng, X, Zeng, Y, Zhan, Yh, Zhang, Aq, Zhang, Bl, Zhang, Bx, Zhang, Dh, Zhang, Gy, Zhang, H, Zhang, Hh, Zhang, Hy, Zhang, Jl, Zhang, Jq, Zhang, Jw, Zhang, Jx, Zhang, Jy, Zhang, Jz, Zhang, Lm, Zhang, Lq, Zhang, L, Zhang, P, Zhang, Qy, Zhang, Sl, Zhang, Xd, Zhang, Xm, Zhang, Xy, Zhang, Y, Zhang, Yt, Zhang, Yh, Zhang, Zh, Zhang, Zy, Zhao, G, Zhao, J, Zhao, Jy, Zhao, Jz, Zhao, L, Zhao, Mg, Zhao, Q, Zhao, Sj, Zhao, Yb, Zhao, Yx, Zhao, Zg, Zhemchugov, A, Zheng, B, Zheng, Jp, Zheng, Yh, Zhong, B, Zhong, C, Zhong, X, Zhou, H, Zhou, Lp, Zhou, X, Zhou, Xk, Zhou, Xr, Zhou, Xy, Zhou, Yz, Zhu, J, Zhu, K, Zhu, Kj, Zhu, Lx, Zhu, Sh, Zhu, Sq, Zhu, Tj, Zhu, Wj, Zhu, Yc, Zhu, Za, Zou, Bs, and Zou, Jh
- Published
- 2022
4. The Atacama Cosmology Telescope: Two-season ACTPol spectra and parameters
- Author
-
Louis, T, Grace, E, Hasselfield, M, Lungu, M, Maurin, L, Addison, GE, Ade, PAR, Aiola, S, Allison, R, Amiri, M, Angile, E, Battaglia, N, Beall, JA, De Bernardis, F, Bond, JR, Britton, J, Calabrese, E, Cho, HM, Choi, SK, Coughlin, K, Crichton, D, Crowley, K, Datta, R, Devlin, MJ, Dicker, SR, Dunkley, J, Dünner, R, Ferraro, S, Fox, AE, Gallardo, P, Gralla, M, Halpern, M, Henderson, S, Hill, JC, Hilton, GC, Hilton, M, Hincks, AD, Hlozek, R, Patty Ho, SP, Huang, Z, Hubmayr, J, Huffenberger, KM, Hughes, JP, Infante, L, Irwin, K, Kasanda, SM, Klein, J, Koopman, B, Kosowsky, A, Li, D, Madhavacheril, M, Marriage, TA, McMahon, J, Menanteau, F, Moodley, K, Munson, C, Naess, S, Nati, F, Newburgh, L, Nibarger, J, Niemack, MD, Nolta, MR, Nuñez, C, Page, LA, Pappas, C, Partridge, B, Rojas, F, Schaan, E, Schmitt, BL, Sehgal, N, Sherwin, BD, Sievers, J, Simon, S, Spergel, DN, Staggs, ST, Switzer, ER, Thornton, R, Trac, H, Treu, J, and Tucker, C
- Subjects
Astrophysics::Instrumentation and Methods for Astrophysics ,Astrophysics::Cosmology and Extragalactic Astrophysics - Abstract
© 2017 IOP Publishing Ltd and Sissa Medialab. We present the temperature and polarization angular power spectra measured by the Atacama Cosmology Telescope Polarimeter (ACTPol). We analyze night-time data collected during 2013-14 using two detector arrays at 149 GHz, from 548 deg2of sky on the celestial equator. We use these spectra, and the spectra measured with the MBAC camera on ACT from 2008-10, in combination with planck and wmap data to estimate cosmological parameters from the temperature, polarization, and temperature-polarization cross-correlations. We find the new ACTPol data to be consistent with the ΛCDM model. The ACTPol temperature-polarization cross-spectrum now provides stronger constraints on multiple parameters than the ACTPol temperature spectrum, including the baryon density, the acoustic peak angular scale, and the derived Hubble constant. The new ACTPol data provide information on damping tail parameters. The joint uncertainty on the number of neutrino species and the primordial helium fraction is reduced by 20% when adding ACTPol to Planck temperature data alone.
- Published
- 2017
- Full Text
- View/download PDF
5. Vaginal compared with intramuscular progestogen for preventing preterm birth in high‐risk pregnant women (VICTORIA study): a multicentre, open‐label randomised trial and meta‐analysis.
- Author
-
Choi, S‐J, Kwak, DW, Kil, K, Kim, S‐C, Kwon, J‐Y, Kim, YH, Na, S, Bae, J‐G, Cha, H‐H, Shim, J‐Y, Oh, KY, Lee, KA, Kim, SM, Cho, IA, Lee, SM, Cho, GJ, Jo, YS, Choi, GY, Choi, SK, and Hur, SE
- Subjects
PREMATURE labor ,PREGNANT women ,INTRAMUSCULAR injections ,PREGNANCY ,PROGESTERONE - Abstract
Objective: To compare the efficacy of two types of progestogen therapy for preventing preterm birth (PTB) and to review the relevant literature. Design: A multicentre, randomised, open‐label, equivalence trial and a meta‐analysis. Setting: Tertiary referral hospitals in South Korea. Population: Pregnant women with a history of spontaneous PTB or short cervical length (<25 mm). Methods: Eligible women were screened and randomised at 16‒22 weeks of gestation to receive either 200 mg of vaginal micronised progesterone daily (vaginal group) or an intramuscular injection of 250 mg 17α‐hydroxyprogesterone caproate weekly (IM group). Stratified randomisation was carried out according to participating centres and indications for progestogen therapy. This trial was registered at ClinicalTrials.gov (NCT02304237). Main outcome measure: Preterm birth (PTB) before 37 weeks of gestation. Results: A total of 266 women were randomly assigned and a total of 247 women (119 and 128 women in the vaginal and IM groups, respectively) were available for the intention‐to‐treat analysis. Risks of PTB before 37 weeks of gestation did not significantly differ between the two groups (22.7 versus 25.8%, P = 0.571). The difference in PTB risk between the two groups was 3.1% (95% CI −7.6 to 13.8%), which was within the equivalence margin of 15%. The meta‐analysis results showed no significant differences in the risk of PTB between the vaginal and IM progestogen treatments. Conclusion: Compared with vaginal progesterone, treatment with intramuscular progestin might increase the risk of PTB before 37 weeks of gestation by as much as 13.8%, or reduce the risk by as much as 7.6%, in women with a history of spontaneous PTB or with short cervical length. Vaginal and intramuscular progestogen showed equivalent efficacy for preventing preterm birth before 37 weeks of gestation. Vaginal and intramuscular progestogen showed equivalent efficacy for preventing preterm birth before 37 weeks of gestation. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
6. Far sidelobe effects from panel gaps of the Atacama Cosmology Telescope
- Author
-
Fluxá, R, Pedro, A, Dünner, R, Maurin, L, Choi, SK, Devlin, MJ, Gallardo, PA, Ho, SP, Koopman, BJ, Louis, T, McMahon, JJ, Nati, F, Niemack, MD, Newburgh, L, Page, LA, Salatino, M, Schillaci, A, Schmitt, BL, Simon, SM, Staggs, ST, Wollack, EJ, Fluxá, R, Pedro, A, Dünner, R, Maurin, L, Choi, S, Devlin, M, Gallardo, P, Ho, S, Koopman, B, Louis, T, Mcmahon, J, Nati, F, Niemack, M, Newburgh, L, Page, L, Salatino, M, Schillaci, A, Schmitt, B, Simon, S, Staggs, S, and Wollack, E
- Subjects
media_common.quotation_subject ,Cosmic microwave background ,Astrophysics::Cosmology and Extragalactic Astrophysics ,Condensed Matter Physic ,01 natural sciences ,Cosmology ,law.invention ,Telescope ,Optics ,law ,Electromagnetic simulation ,Optical Simulation ,Polarization ,0103 physical sciences ,Cosmic Microwave Background ,Electronic ,Electrical and Electronic Engineering ,010303 astronomy & astrophysics ,Astrophysics::Galaxy Astrophysics ,media_common ,Physics ,Farsidelobe ,010308 nuclear & particles physics ,Gravitational wave ,business.industry ,Astrophysics::Instrumentation and Methods for Astrophysics ,Astronomy ,Spectral density ,Optical and Magnetic Material ,Computer Science Applications1707 Computer Vision and Pattern Recognition ,Polarization (waves) ,Applied Mathematic ,B-mode ,Sky ,Atacama Cosmology Telescope ,Astrophysics::Earth and Planetary Astrophysics ,business ,Diffraction - Abstract
The Atacama Cosmology Telescope is a 6 meter diameter CMB telescope located at 5200 meters in the Chilean desert. ACT has made arc-minute scale maps of the sky at 90 and 150 GHz which have led to precise measurements of the fine angular power spectrum of the CMB fluctuations in temperature and polarization. One of the goals of ACT is to search for the B-mode polarization signal from primordial gravity waves, and thus extending ACT’s data analysis to larger angular scales. This goal introduces new challenges in the control of systematic effects, including better understanding of far sidelobe effects that might enter the power spectrum at degree angular scales. Here we study the effects of the gaps between panels of the ACT primary and secondary reflectors in the worst case scenario in which the gaps remain open. We produced numerical simulations of the optics using GRASP up to 8 degrees away from the main beam and simulated timestreams for observations with this beam using real pointing information from ACT data. Maps from these simulated timestreams showed leakage from the sidelobes, indicating that this effect must be taken into consideration at large angular scales.
- Published
- 2016
7. Evidence for the decay B0 --> K+K-pi0
- Author
-
Collaboration, TB, Gaur, V, Mohanty, GB, Aziz, T, Adachi, I, Aihara, H, Asner, DM, Aulchenko, V, Aushev, T, Bakich, AM, Bala, A, Belous, K, Bhardwaj, V, Bhuyan, B, Bonvicini, G, Bozek, A, Bracko, M, Browder, TE, Chang, P, Chekelian, V, Chen, A, Chen, P, Cheon, BG, Chistov, R, Cho, K, Chobanova, V, Choi, SK, Choi, Y, Cinabro, D, Dalseno, J, Danilov, M, Dolezal, Z, Drasal, Z, Drutskoy, A, Dutta, D, Dutta, K, Eidelman, S, Farhat, H, Feindt, M, Ferber, T, Frey, A, Gabyshev, N, Ganguly, S, Gillard, R, Goh, YM, Golob, B, Haba, J, Hayashii, H, Horii, Y, Hoshi, Y, Hou, WS, Hyun, HJ, Iijima, T, Ishikawa, A, Itoh, R, Iwasaki, Y, Julius, T, Kah, DH, Kang, JH, Kawasaki, T, Kiesling, C, Kim, HJ, Kim, JB, Kim, JH, Kim, KT, Kim, MJ, Kim, YJ, Kinoshita, K, Klucar, J, Ko, BR, Kodys, P, Korpar, S, Krizan, P, Kumar, R, Kumita, T, Kwon, YJ, Lange, JS, Lee, SH, Li, J, Li, Y, Libby, J, Liu, C, Liventsev, D, Lukin, P, Matvienko, D, Miyabayashi, K, Miyata, H, Muramatsu, N, Mussa, R, Nakano, E, Nakao, M, Nayak, M, Nedelkovska, E, Nisar, NK, Nishida, S, Nitoh, O, Ogawa, S, Okuno, S, Onuki, Y, Ostrowicz, W, Pakhlov, P, Pakhlova, G, Park, H, Park, HK, Pedlar, TK, Pestotnik, R, Petric, M, Piilonen, LE, Ritter, M, Rohrken, M, Rostomyan, A, Sahoo, H, Saito, T, Sakai, Y, Sandilya, S, Santel, D, Sanuki, T, Sato, Y, Savinov, V, Schneider, O, Schnell, G, Schwanda, C, Semmler, D, Senyo, K, Seon, O, Sevior, ME, Shapkin, M, Shen, CP, Shibata, TA, Shiu, JG, Sibidanov, A, Simon, F, Singh, JB, Sinha, R, Smerkol, P, Sohn, YS, Sokolov, A, Solovieva, E, Staric, M, Steder, M, Sumihama, M, Sumiyoshi, T, Tamponi, U, Tatishvili, G, Teramoto, Y, Tsuboyama, T, Uchida, M, Uehara, S, Uglov, T, Unno, Y, Uno, S, Vahsen, SE, Hulse, CV, Vanhoefer, P, Varner, G, Varvell, KE, Vorobyev, V, Wagner, MN, Wang, CH, Wang, P, Wang, XL, Watanabe, M, Watanabe, Y, Williams, KM, Won, E, Yabsley, BD, Yamashita, Y, Yashchenko, S, Yusa, Y, Zhilich, V, and Zupanc, A
- Subjects
High Energy Physics - Phenomenology ,High Energy Physics::Experiment ,Nuclear Experiment ,High Energy Physics - Experiment - Abstract
We report a search for charmless hadronic decays of neutral B mesons to the final state K+K-pi0. The results are based on a 711 fb^-1 data sample that contains 772x10^6 BB-bar pairs, and was collected at the Y(4S) resonance with the Belle detector at the KEKB asymmetric-energy e+e- collider. We find the first evidence for this decay with a significance of 3.5 standard deviations and measure its branching fraction as BF(B0 --> K+K-pi0) = [2.17 +/- 0.60(stat) +/- 0.24 (syst)]x10^-6., Comment: 7 pages, 6 figures, published in Phys. Rev. D
- Published
- 2013
8. Radiative B meson decays into K pi gamma and K pi pi gamma final states
- Author
-
Nishida, S, Nakao, M, Abe, K, Abe, T, Ahn, BS, Aihara, H, Akatsu, M, Asano, Y, Aushev, T, Bakich, AM, Ban, Y, Banas, E, Bartel, W, Bay, A, Bedny, I, Bondar, A, Bozek, A, Bracko, M, Brodzicka, J, Browder, TE, Casey, BCK, Chang, P, Chao, Y, Cheon, BG, Chistov, R, Choi, SK, Choi, Y, Danilov, M, Dong, LY, Drutskoy, A, Eidelman, S, Eiges, V, Enari, Y, Fukunaga, C, Gabyshev, N, Gershon, T, Gordon, A, Gotow, K, Guo, R, Haba, J, Hara, T, Hayashii, H, Hazumi, M, Heenan, EM, Higuchi, I, Higuchi, T, Hojo, T, Hokuue, T, Hoshi, Y, Hou, SR, Hou, WS, Hsu, SC, Huang, HC, Igaki, T, Iijima, T, Inami, K, Ishikawa, A, Ishino, H, Itoh, R, Iwamoto, M, Iwasaki, H, Iwasaki, Y, Jalocha, P, Jang, HK, Kang, JH, Kapusta, P, Kataoka, SU, Katayama, N, Kawai, H, Kawakami, Y, Kawamura, N, Kawasaki, T, Kichimi, H, Kim, DW, Kim, H, Kim, HJ, Kim, HO, Kim, TH, Kinoshita, K, Krizan, P, Krokovny, P, Kulasiri, R, Kumar, S, Kwon, YJ, Lange, JS, Leder, G, Lee, SH, Li, J, Lu, RS, MacNaughton, J, Majumder, G, Mandl, F, Matsumoto, S, Matsumoto, T, Mikami, Y, Mitaroff, W, Miyabayashi, K, Miyake, H, Miyata, H, Moloney, GR, Mori, S, Nagamine, T, Nagasaka, Y, Nakadaira, T, Nakano, E, Nam, JW, Natkaniec, Z, Neichi, K, Nitoh, O, Noguchi, S, Nozaki, T, Ogawa, S, Ohno, F, Ohshima, T, Okabe, T, Okuno, S, Olsen, SL, Ostrowicz, W, Ozaki, H, Pakhlov, P, Palka, H, Park, CW, Park, H, Park, KS, Peak, LS, Perroud, JP, Peters, M, Piilonen, LE, Rozanska, M, Rybicki, K, Sagawa, H, Saitoh, S, Sakai, Y, Sakamoto, H, Satapathy, M, Satpathy, A, Schneider, O, Schrenk, S, Schwanda, C, Semenov, S, Senyo, K, Seuster, R, Sevior, ME, Shibuya, H, Shwartz, B, Sidorov, V, Singh, JB, Stanic, S, Sugi, A, Sugiyama, A, Sumisawa, K, Sumiyoshi, T, Suzuki, K, Suzuki, S, Takahashi, T, Takasaki, F, Tamai, K, Tamura, N, Tanaka, M, Taylor, GN, Teramoto, Y, Tokuda, S, Tomoto, M, Tomura, T, Tovey, SN, Trabelsi, K, Tsuboyama, T, Tsukamoto, T, Uehara, S, Ueno, K, Uno, S, Ushiroda, Y, Varner, G, Varvell, KE, Wang, CC, Wang, CH, Wang, JG, Wang, MZ, Watanabe, Y, Won, E, Yabsley, BD, Yamada, Y, Yamaguchi, A, Yamamoto, H, Yamashita, Y, Yamauchi, M, Yuan, Y, Yusa, Y, Zhang, J, Zhang, ZP, Zhilich, V, and Zontar, D
- Published
- 2002
9. Comparison of hybrid natural orifice transluminal endoscopic surgery and single-port laparoscopic surgery for sentinel node basin dissection in a porcine model.
- Author
-
Jeong SH, Lee YJ, Yoo MW, Park ST, Choi SK, Hong SC, Jung EJ, Ju YT, Jeong CY, and Ha WS
- Published
- 2012
10. Femtosecond laser creates thin corneal graft for limbal stem cell transplantation.
- Author
-
Lee D, Kim JH, Choi SK, and John T
- Subjects
CORNEA physiology ,CORNEA diseases ,LIMBAL stem cells ,LASER therapy ,CORNEAL transplantation ,STEM cells ,CORNEA - Published
- 2009
11. Surgical clips found at the hepatic duct after laparoscopic cholecystectomy: a possible case of clip migration.
- Author
-
Ahn S, Lee K, Kim SJ, Cho EH, Choi SK, Hur YS, Cho YU, Hong K, Shin S, Kim KR, Woo Z, Jeong S, Ahn, Seung-Ik, Lee, Keon-Young, Kim, Sei Joong, Cho, Eung Ho, Choi, Sun Keun, Hur, Yoon Seok, Cho, Young Up, and Hong, Kee-Chun
- Published
- 2005
- Full Text
- View/download PDF
12. Whiplash Injury-induced Atypical Short-lasting Unilateral Neuralgiform Headache With Conjunctival Injection and Tearing Syndrome Treated by Greater Occipital Nerve Block.
- Author
-
Choi HJ, Choi SK, Lee SH, and Lim YJ
- Published
- 2012
- Full Text
- View/download PDF
13. Gastrointestinal: Large mucin pool within the remnant stalk of an adenomatous polyp after resection and its association with colitis cystica profunda.
- Author
-
Shin, OR, Kim, NY, Choi, SK, and Cho, YS
- Subjects
COLON tumors ,RECTUM tumors ,COLON polyps ,SIGMOID colon ,COLONOSCOPY ,DIAGNOSIS - Abstract
The article presents a case study of a 65-year-old man who was referred to a hospital for management of the colon polyp. He underwent a colonoscopy, which showed a pedunculated polyp with a long, thick stalk in the proximal sigmoid colon, and endoscopic polypectomy. He was diagnosed with colitis cystica profunda (CCP), a rare benign lesion of the colon and rectum.
- Published
- 2014
- Full Text
- View/download PDF
14. The Relationship Between a Hospital's Magnet Status and LGBTQ+ Inclusivity in Policies and Practices in US Hospitals.
- Author
-
Yu H, Bonett S, Flores DD, Meanley S, Choi SK, Hanneman T, and Bauermeister JA
- Subjects
- Humans, United States, Female, Hospitals standards, Male, Healthcare Disparities, Sexual and Gender Minorities statistics & numerical data
- Abstract
LGBTQ+ individuals face discrimination in healthcare settings. Magnet hospitals have been associated with positive patient outcomes, yet it remains uncertain whether Magnet designation is associated with hospitals' LGBTQ+ inclusivity in policies and practices. This study examined 801 American hospitals across 47 states that participated in the Healthcare Equality Index (HEI) in 2021. Multilevel modeling was utilized to investigate the association between Magnet status and HEI scores, adjusting for hospital type and state-level covariates, including LGBTQ+ inclusiveness in laws, political climate, racial/ethnic minority population, and Medicaid expansion status. Among the 801 hospitals, 32.1% (257 hospitals) held Magnet status. Magnet hospitals demonstrated higher HEI scores compared to non-Magnet hospitals (γ = 2.13, p = 0.022), despite significant variations across states (intraclass correlation = 0.22). No significant cross-level interactions were found. Overall, Magnet designation is independently associated with improved LGBTQ+ inclusivity in hospitals regardless of the state in which the hospital is located. Policymakers and healthcare leaders should consider leveraging the Magnet Recognition Program as a benchmark for promoting LGBTQ+ inclusivity within hospitals. Additionally, all healthcare institutions should prioritize comprehensive evaluations and improvements to their policies and practices to ensure inclusivity for LGBTQ+ patients., (© 2024 The Author(s). Research in Nursing & Health published by Wiley Periodicals LLC.)
- Published
- 2025
- Full Text
- View/download PDF
15. Immortalization of epidural fat-derived mesenchymal stem cells: In vitro characterization and adipocyte differentiation potential.
- Author
-
Lee SW, Lim YJ, Kim HY, Kim W, Park WT, Ma MJ, Lee J, Seo MS, Kim YI, Park S, Choi SK, and Lee GW
- Abstract
Background: Mesenchymal stem cells (MSCs) are promising candidates for regenerative therapy due to their self-renewal capability, multilineage differentiation potential, and immunomodulatory effects. The molecular characteristics of MSCs are influenced by their location. Recently, epidural fat (EF) and EF-derived MSCs (EF-MSCs) have garnered attention due to their potential benefits to the spinal microenvironment and their high expression of neural SC markers. However, their clinical applications are limited due to cell senescence and limited accessibility of EF. Although many studies have attempted to establish an immortalized, stable SC line, the characteristics of immortalized EF-MSCs remain to be clarified., Aim: To establish and analyze stable immortalized EF-MSCs., Methods: The phenotypes of EF-MSCs were analyzed using optical microscopy. Cell immortalization was performed using lentiviral vectors. The biomolecular characteristics of the cells were analyzed by immunoblotting, quantitative PCR, and proteomics., Results: The immortalized EF-MSCs demonstrated a significantly extended lifespan compared to the control group, with well-preserved adipogenic potential and SC surface marker expression. Introduction of human telomerase reverse transcriptase genes markedly increased the lifespan of EF-MSCs. Proteomics analysis revealed substantial increase in the expression of DNA replication pathway components in immortalized EF-MSCs., Conclusion: Immortalized EF-MSCs exhibited significantly enhanced proliferative capacity, retained adipogenic potential, and upregulated the expression of DNA replication pathway components., Competing Interests: Conflict-of-interest statement: The authors have no conflicts of interest to declare., (©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.)
- Published
- 2025
- Full Text
- View/download PDF
16. Association between COVID-19 anxiety syndrome and COVID-19 vaccine hesitancy in the postpandemic era: a cross-sectional study in Hong Kong.
- Author
-
Wu TCM, Ho JKM, Choi SK, Chan YHY, Chan BWS, Li TTM, Tam FP, Wong IMC, and Wing Chan AS
- Subjects
- Humans, Hong Kong epidemiology, Cross-Sectional Studies, Male, Female, Adult, Middle Aged, Young Adult, Surveys and Questionnaires, Aged, Anxiety epidemiology, Anxiety psychology, Adolescent, Anxiety Disorders epidemiology, Anxiety Disorders psychology, COVID-19 prevention & control, COVID-19 epidemiology, COVID-19 psychology, COVID-19 Vaccines administration & dosage, Vaccination Hesitancy psychology, Vaccination Hesitancy statistics & numerical data
- Abstract
Background: The COVID-19 pandemic has had profound psychophysiological and socioeconomic effects worldwide. COVID-19 anxiety syndrome (CAS) is a specific cluster of maladaptive coping strategies, including perseveration and avoidance behaviours, in response to the perceived threat and fear of COVID-19. CAS is distinct from general COVID-19 anxiety. The level of CAS in the postpandemic era remained unknown. Despite extensive research on general COVID-19 anxiety and COVID-19 vaccine hesitancy (CVH), few studies have investigated the association between CAS and CVH. The present study aimed to assess the level of CAS and the prevalence of CVH and explore the association between CAS and CVH in the general population of Hong Kong., Methods: This cross-sectional study was conducted in Hong Kong. Participants were recruited using convenience and snowball sampling methods and completed an online or a paper-based questionnaire comprising two well-validated instruments. The COVID-19 Anxiety Syndrome Scale (C-19ASS), which includes the C-19ASS-P and C-19ASS-A subscales, was used to evaluate CAS in terms of perseveration and avoidance behaviours. The COVID-19 Vaccine Hesitancy Scale (CVHS) was used to determine the presence of CVH., Results: This study included 389 participants. The median C-19ASS-P and C-19ASS-A scores were 8 (Interquartile range (IQR) 5-13) and 3 (IQR 0-6), respectively. The CVHS scores revealed a CVH prevalence of 68.1%. A significantly larger proportion of participants with CVH rated "hesitant" compared with those without CVH across all the CVHS items. Furthermore, the median C-19ASS-P and C-19ASS-A scores were significantly higher for participants without CVH than for those with CVH., Conclusions: Our findings revealed that CAS persists and CVH is common in the postpandemic era and that CAS is associated with CVH. Comprehensive interventions addressing both informational and psychological aspects are needed to increase the rate of vaccine acceptance and to mitigate the effect of CAS on public health outcomes., Competing Interests: Declarations. Ethics approval and consent to participate: The present study was approved by the Research Ethics Committee of the School of Nursing and Health Studies at Hong Kong Metropolitan University. The participants were informed about the study objectives before giving written consent. The procedures followed the ethical principles of the Declaration of Helsinki. The participants’ rights to confidentiality, autonomy, and data privacy were respected throughout the study period. Participation in this study was entirely voluntary and no compensation was offered to participants. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests., (© 2025. The Author(s).)
- Published
- 2025
- Full Text
- View/download PDF
17. Identification of Sulcal Hyperintense Vessel (Vessel Wall MR Ivy Sign) in Adult Moyamoya Disease with High-resolution Vessel Wall Imaging : A Pilot Study.
- Author
-
Park JI, Hong JS, Ryu J, Lee KM, Woo HG, and Choi SK
- Abstract
Objective: The leptomeningeal ivy sign is a distinctive finding of moyamoya disease (MMD), characterized by a linear high signal intensity along the cortical sulci on contrast-enhanced T1 magnetic resonance imaging (MRI) and fluid-attenuated inversion-recovery MRI. We recently identified a similar linear enhancement along the cortical sulci using gadolinium-enhanced vessel wall MRI (VWMR) in patients with MMD. The aim of this study was to introduce the concept of the "VWMR ivy sign (VIS)"., Methods: Eighteen MMD patients underwent gadolinium-enhanced VWMR. We identified the VIS in gadolinium-enhanced VWMR, represented by a linear high intensity along the cortical sulci. The VIS was assessed by comparing pre and postcontrast T1 black blood sequences on VWMR and was investigated in the precentral, central, and postcentral sulci. "VIS scores" were calculated by the sum of VIS in the three sulci, ranged from 0 to 3. We compared the VIS scores according to different stroke presentations (non-stroke, ischemic stroke, and hemorrhagic stroke). The inter-modality agreement for identifying VIS and fluid-attenuated inversion-recovery (FLAIR)/cortical sulci on contrast-enhanced T1 MRI (CEMR) ivy sign was determined using Cohen's kappa statistics., Results: The VIS scores were significantly different among the three groups (P = 0.004). The VIS scores in both the ischemic and hemorrhagic groups were significantly higher than those in the non-stroke group (ischemic vs. non-stroke, P = 0.009; hemorrhagic vs. non-stroke, P = 0.004). After adjusting for age and sex using the non-stroke group as a reference group, the VIS scores were significantly higher in the ischemic and hemorrhagic groups (P=0.046, OR 8.27, 95% CI 1.03-66.19 and P=0.039, OR 7.78, 95% CI 1.11-54.48, respectively). Inter-modality agreement between VIS and FLAIR ivy sign was substantial, perfect, and substantial in the precentral, central, and postcentral sulci, respectively (precentral sulcus, κ=0.609, 95% CI=0.213-1; central sulcus, κ=1; and postcentral sulcus, κ=0.769, 95% CI=0.475-1). Inter-modality agreement between the VIS and CEMR ivy sign was substantial in the precentral, central, and postcentral sulci, respectively (precentral sulcus, κ=0.727, 95% CI=0.384-1; central sulcus, κ=0.609, 95% CI=0.384-1; and postcentral sulcus, κ=0.649, 95% CI=0.310-0.998)., Conclusion: This preliminary series introduces the concept of VIS, possibly indicating slow and retrograde flow of sulcal vessels via leptomeningeal collaterals. Future studies are needed to develop an optimal scoring system for VIS and establish its clinical correlation with stroke presentations in MMD patients.
- Published
- 2025
- Full Text
- View/download PDF
18. Impact of a Virtual Care Navigation Service on Member-Reported Outcomes Among Lesbian, Gay, Bisexual, Transgender, and Queer Populations: Case Study.
- Author
-
Choi SK, Marshall J, Sexton Topper P, Pregnall A, and Bauermeister J
- Subjects
- Humans, Male, Female, Adult, Middle Aged, Health Services Accessibility, Sexual and Gender Minorities, Patient Navigation organization & administration
- Abstract
Background: While the significance of care navigation in facilitating access to health care within the lesbian, gay, bisexual, transgender, queer, and other (LGBTQ+) communities has been acknowledged, there is limited research examining how care navigation influences an individual's ability to understand and access the care they need in real-world settings. By analyzing private sector data, we can bridge the gap between theoretical research findings and practical applications, ultimately informing both business strategies and public policy with evidence grounded in real-world efficacy., Objective: The objective of this study was to evaluate the impact of specialized virtual care navigation services on LGBTQ+ individuals' ability to comprehend and access necessary care within a national cohort of commercially insured members., Methods: This case study is based on the experience of commercially insured members, aged 18 or older, who used the LGBTQ+ Health Care Navigation (LGBTQ+ Navigation) service by Included Health between January 26 and July 31, 2023. Care coordinators assisted members by connecting them with vetted identity-affirming in-network providers, helping them navigate and understand their LGBTQ+ health benefits, and providing education and advocacy for clinical and nonclinical needs. We examined the impact of navigation on 5 member-reported outcomes. In addition to reporting the proportion who agreed or strongly agreed, we calculated an impact score that averaged assigned numerical values to all 5 question responses (1=strongly disagree to 5=strongly agree) for each respondent. We used ANOVA with Tukey post hoc tests and t tests to explore the relationships between the impact score and member characteristics, including optional self-reported demographics., Results: Out of 4703 LGBTQ+ Navigation cases, 7.53% (n=354) had member-reported outcomes. A large majority of LGBTQ+ members agreed or strongly agreed that care navigation resulted in less stress (315/354, 89%), less care avoidance (305/354, 86.2%), higher confidence in finding an identity-affirming provider (327/354, 92.4%), improved ability to comprehend health care information (312/354, 88.1%), and improved ability to engage with providers (308/354, 87%). The average impact score was 4.44 (SD 0.69), with statistically significant differences by gender identity (P=.003), race (P=.01), ethnicity (P=.008), and pronouns (P=.02). The scores were highest for members with multiple gender identities (mean 4.56, SD 0.37), and members who did not provide their race, ethnicity, or their pronouns (mean 4.55, SD 0.64). Impact scores were lowest for transgender members (mean 4.11, SD 0.95)., Conclusions: The LGBTQ+ Navigation service, by enhancing members' comprehension and use of necessary care, demonstrates potential public health utility and value. Continuous evaluation of navigation services can serve as a supplementary tool for employers seeking to promote health equity and improve belonging among employees. This is particularly important as discrimination and stigma against LGBTQ+ communities persist in the United States. Therefore, scalable and system-level changes that use navigation services are essential to reach a larger proportion of the LGBTQ+ population., (© Seul Ki Choi, Jaclyn Marshall, Patrina Sexton Topper, Andrew Pregnall, José Bauermeister. Originally published in JMIR Formative Research (https://formative.jmir.org).)
- Published
- 2025
- Full Text
- View/download PDF
19. Phosphorylation of BRCA1 at serine 1387 plays a critical role in cathepsin S-mediated radiation resistance via BRCA1 degradation and BCL2 stabilization.
- Author
-
Mun GI, Choi E, Jin H, Choi SK, Lee H, Kim S, Kim J, Kang C, Oh HL, Lee HJ, Ahn DR, and Lee YS
- Subjects
- Humans, Cell Line, Tumor, Female, Phosphorylation radiation effects, Serine metabolism, Protein Stability radiation effects, Apoptosis radiation effects, Ataxia Telangiectasia Mutated Proteins metabolism, BRCA1 Protein metabolism, BRCA1 Protein genetics, Proto-Oncogene Proteins c-bcl-2 metabolism, Proto-Oncogene Proteins c-bcl-2 genetics, Cathepsins metabolism, Cathepsins genetics, Triple Negative Breast Neoplasms metabolism, Triple Negative Breast Neoplasms radiotherapy, Triple Negative Breast Neoplasms pathology, Triple Negative Breast Neoplasms genetics, Radiation Tolerance, Proteolysis radiation effects
- Abstract
There is evidence that BRCA1, particularly cytoplasmic BRCA1, plays a significant role in initiating apoptosis through various mechanisms. Maintaining the stability of BRCA1 in cancer cells may be a promising therapeutic strategy for breast cancer, especially in cases of triple-negative breast cancer (TNBC) lacking appropriate therapeutic targets. Previously, it was reported that cathepsin S (CTSS) interacts with the BRCT domain of BRCA1, leading to ubiquitin-mediated degradation. We further investigated the critical role of BRCA1 phosphorylation at Ser1387, which is mediated by ionizing radiation (IR)-induced activation of ATM. This phosphorylation event was identified as a key factor in CTSS-mediated ubiquitin degradation of BRCA1. The functional inhibition of CTSS, using small molecules or a knockdown system, sensitized TNBC cells when exposed to IR by restoring the stability of cytoplasmic BRCA1. The increase in cytoplasmic BRCA1 led to the degradation of anti-apoptotic BCL2, which was responsible for the radiosensitization effect observed with CTSS inhibition. These results suggest that inhibiting CTSS may be an effective strategy for radiosensitization in TNBC cells through BCL2 degradation that is mediated by inhibition of CTSS-induced BRCA1 degradation., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. TNBC cell lines were exposed to irradiation (10 Gy) after pre-treatment with CTSS inhibitors; RO5461111 (RO) and Z-FL-COCHO (Z-FL). TNBC cell lines with wild-type BRCA1 (WT); MDA-MB-231 (231) & HCC70 and mutant BRCA1 (MT); MDA-MB-436 (436) & HCC1937 (1937). (A) Western blot analysis and the quantification of cleaved-PARP1 induction; (B) Cell death was evaluated with PI staining. Results are the means and SD (*p < 0.05, ANOVA)., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2025
- Full Text
- View/download PDF
20. HIV Outcomes and Intervention Experiences of Enlaces Por La Salud: A Personal Health Navigation Intervention Informed by the Transnational Framework.
- Author
-
Hightow-Weidman LB, Choi SK, Higgins ICA, Knudtson K, and Barrington C
- Abstract
Latinos in the United States are disproportionately affected by HIV and experience sub-optimal levels of viral suppression. Enlaces Por La Salud is an individual-level intervention implemented by personal health navigators and guided by the transnational framework to improve HIV care outcomes among newly diagnosed and out-of-care Mexican and Mexican American men and transgender women in North Carolina. The purpose of this study was to assess: (1) changes in HIV care and treatment outcomes among Enlaces participants and (2) intervention engagement and experiences. Ninety-one participants were recruited between October 2014 and August 2017 for a single-arm, mixed-methods design including surveys at baseline, 6 and 12 months and qualitative in-depth interviews immediately following the intervention with an embedded cohort (n = 19). Mean participant age was 36.8 years and most identified as cisgender male (90%). Participants were significantly more likely to have an undetectable viral load at baseline (18%) compared to 6-months (78%) (p < .001). Outcomes were sustained but not significantly increased from 6 to 12 months. Intervention engagement was high with 81% completing all six intervention sessions. In qualitative interviews, participants emphasized the importance of their relationship with the personal health navigators, who provided information, instrumental, and emotional support. A person-centered intervention guided by the lived experience of migration could be an effective way to support Latinos with HIV from diverse countries of origin to achieve viral suppression and improve overall wellbeing., Competing Interests: Declarations. Competing Interests: The authors report no financial or non-financial interests that are directly or indirectly related to the work submitted for publication., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2025
- Full Text
- View/download PDF
21. Evidence of h_{b}(2P)→ϒ(1S)η Decay and Search for h_{b}(1P,2P)→ϒ(1S)π^{0} with the Belle Detector.
- Author
-
Kovalenko E, Adachi I, Aihara H, Asner DM, Aushev T, Ayad R, Babu V, Banerjee S, Belous K, Bennett J, Bessner M, Bilka T, Biswas D, Bobrov A, Bodrov D, Bondar A, Bozek A, Bračko M, Branchini P, Browder TE, Budano A, Campajola M, Chang MC, Cheon BG, Chilikin K, Cho HE, Cho K, Cho SJ, Choi SK, Choi Y, Choudhury S, Dash N, De Nardo G, De Pietro G, Dhamija R, Di Capua F, Doležal Z, Dong TV, Dubey S, Ecker P, Epifanov D, Ferlewicz D, Fulsom BG, Garg R, Gaur V, Garmash A, Giri A, Goldenzweig P, Graziani E, Gu T, Guan Y, Gudkova K, Hadjivasiliou C, Hara T, Hayasaka K, Hazra S, Hou WS, Hsu CL, Inami K, Ipsita N, Ishikawa A, Itoh R, Iwasaki M, Jacobs WW, Jin Y, Kawasaki T, Kiesling C, Kim CH, Kim DY, Kim KH, Kim YK, Kinoshita K, Kodyš P, Korobov A, Korpar S, Križan P, Krokovny P, Kuhr T, Kumar R, Kumara K, Kuzmin A, Kwon YJ, Lai YT, Lam T, Levit D, Li LK, Li Gioi L, Libby J, Liventsev D, Ma Y, Martini A, Masuda M, Matsuda T, Matvienko D, Meier F, Merola M, Miyabayashi K, Mizuk R, Mohanty GB, Mussa R, Nakamura I, Nakao M, Natkaniec Z, Natochii A, Nayak L, Nayak M, Niiyama M, Nishida S, Ogawa S, Ono H, Pakhlova G, Pardi S, Park J, Park SH, Passeri A, Patra S, Paul S, Pedlar TK, Pestotnik R, Piilonen LE, Podobnik T, Prencipe E, Prim MT, Purohit MV, Rout N, Russo G, Sandilya S, Santelj L, Savinov V, Schnell G, Schwanda C, Seino Y, Senyo K, Sevior ME, Shan W, Sharma C, Shiu JG, Shwartz B, Sokolov A, Solovieva E, Starič M, Sumihama M, Takizawa M, Tamponi U, Tanida K, Tenchini F, Tiwary R, Uchida M, Unno Y, Uno S, Usov Y, Vinokurova A, Wang D, Wang E, Wang MZ, Wang XL, Won E, Yabsley BD, Yan W, Yang SB, Yelton J, Yin JH, Yook Y, Yuan CZ, Zhang ZP, and Zhilich V
- Abstract
We report the first evidence for the h_{b}(2P)→ϒ(1S)η transition with a significance of 3.5 standard deviations. The decay branching fraction is measured to be B[h_{b}(2P)→ϒ(1S)η]=(7.1_{-3.2}^{+3.7}±0.8)×10^{-3}, which is noticeably smaller than expected. We also set upper limits on π^{0} transitions of B[h_{b}(2P)→ϒ(1S)π^{0}]<1.8×10^{-3}, and B[h_{b}(1P)→ϒ(1S)π^{0}]<1.8×10^{-3}, at the 90% confidence level. These results are obtained with a 131.4 fb^{-1} data sample collected near the ϒ(5S) resonance with the Belle detector at the KEKB asymmetric-energy e^{+}e^{-} collider.
- Published
- 2024
- Full Text
- View/download PDF
22. Precise Measurement of the e^{+}e^{-}→D_{s}^{+}D_{s}^{-} Cross Section at Center-of-Mass Energies from Threshold to 4.95 GeV.
- Author
-
Ablikim M, Achasov MN, Adlarson P, Afedulidis O, Ai XC, Aliberti R, Amoroso A, An Q, Bai Y, Bakina O, Balossino I, Ban Y, Bao HR, Batozskaya V, Begzsuren K, Berger N, Berlowski M, Bertani M, Bettoni D, Bianchi F, Bianco E, Bortone A, Boyko I, Briere RA, Brueggemann A, Cai H, Cai X, Calcaterra A, Cao GF, Cao N, Cetin SA, Chang JF, Che GR, Chelkov G, Chen C, Chen CH, Chen C, Chen G, Chen HS, Chen HY, Chen ML, Chen SJ, Chen SL, Chen SM, Chen T, Chen XR, Chen XT, Chen YB, Chen YQ, Chen ZJ, Chen ZY, Choi SK, Cibinetto G, Cossio F, Cui JJ, Dai HL, Dai JP, Dbeyssi A, de Boer RE, Dedovich D, Deng CQ, Deng ZY, Denig A, Denysenko I, Destefanis M, De Mori F, Ding B, Ding XX, Ding Y, Ding Y, Dong J, Dong LY, Dong MY, Dong X, Du MC, Du SX, Duan YY, Duan ZH, Egorov P, Fan YH, Fang J, Fang J, Fang SS, Fang WX, Fang Y, Fang YQ, Farinelli R, Fava L, Feldbauer F, Felici G, Feng CQ, Feng JH, Feng YT, Fritsch M, Fu CD, Fu JL, Fu YW, Gao H, Gao XB, Gao YN, Gao Y, Garbolino S, Garzia I, Ge L, Ge PT, Ge ZW, Geng C, Gersabeck EM, Gilman A, Goetzen K, Gong L, Gong WX, Gradl W, Gramigna S, Greco M, Gu MH, Gu YT, Guan CY, Guo AQ, Guo LB, Guo MJ, Guo RP, Guo YP, Guskov A, Gutierrez J, Han KL, Han TT, Hanisch F, Hao XQ, Harris FA, He KK, He KL, Heinsius FH, Heinz CH, Heng YK, Herold C, Holtmann T, Hong PC, Hou GY, Hou XT, Hou YR, Hou ZL, Hu BY, Hu HM, Hu JF, Hu SL, Hu T, Hu Y, Huang GS, Huang KX, Huang LQ, Huang XT, Huang YP, Huang YS, Hussain T, Hölzken F, Hüsken N, In der Wiesche N, Jackson J, Janchiv S, Jeong JH, Ji Q, Ji QP, Ji W, Ji XB, Ji XL, Ji YY, Jia XQ, Jia ZK, Jiang D, Jiang HB, Jiang PC, Jiang SS, Jiang TJ, Jiang XS, Jiang Y, Jiao JB, Jiao JK, Jiao Z, Jin S, Jin Y, Jing MQ, Jing XM, Johansson T, Kabana S, Kalantar-Nayestanaki N, Kang XL, Kang XS, Kavatsyuk M, Ke BC, Khachatryan V, Khoukaz A, Kiuchi R, Kolcu OB, Kopf B, Kuessner M, Kui X, Kumar N, Kupsc A, Kühn W, Lane JJ, Larin P, Lavezzi L, Lei TT, Lei ZH, Lellmann M, Lenz T, Li C, Li C, Li CH, Li C, Li DM, Li F, Li G, Li HB, Li HJ, Li HN, Li H, Li JR, Li JS, Li K, Li LJ, Li LK, Li L, Li MH, Li PR, Li QM, Li QX, Li R, Li SX, Li T, Li WD, Li WG, Li X, Li XH, Li XL, Li XY, Li XZ, Li YG, Li ZJ, Li ZY, Liang C, Liang H, Liang H, Liang YF, Liang YT, Liao GR, Liao LZ, Liao YP, Libby J, Limphirat A, Lin CC, Lin DX, Lin T, Liu BJ, Liu BX, Liu C, Liu CX, Liu F, Liu FH, Liu F, Liu GM, Liu H, Liu HB, Liu HH, Liu HM, Liu H, Liu JB, Liu JY, Liu K, Liu KY, Liu K, Liu L, Liu LC, Liu L, Liu MH, Liu PL, Liu Q, Liu SB, Liu T, Liu WK, Liu WM, Liu X, Liu X, Liu Y, Liu Y, Liu YB, Liu ZA, Liu ZD, Liu ZQ, Lou XC, Lu FX, Lu HJ, Lu JG, Lu XL, Lu Y, Lu YP, Lu ZH, Luo CL, Luo JR, Luo MX, Luo T, Luo XL, Lyu XR, Lyu YF, Ma FC, Ma H, Ma HL, Ma JL, Ma LL, Ma MM, Ma QM, Ma RQ, Ma T, Ma XT, Ma XY, Ma Y, Ma YM, Maas FE, Maggiora M, Malde S, Mao YJ, Mao ZP, Marcello S, Meng ZX, Messchendorp JG, Mezzadri G, Miao H, Min TJ, Mitchell RE, Mo XH, Moses B, Muchnoi NY, Muskalla J, Nefedov Y, Nerling F, Nie LS, Nikolaev IB, Ning Z, Nisar S, Niu QL, Niu WD, Niu Y, Olsen SL, Ouyang Q, Pacetti S, Pan X, Pan Y, Pathak A, Patteri P, Pei YP, Pelizaeus M, Peng HP, Peng YY, Peters K, Ping JL, Ping RG, Plura S, Prasad V, Qi FZ, Qi H, Qi HR, Qi M, Qi TY, Qian S, Qian WB, Qiao CF, Qiao XK, Qin JJ, Qin LQ, Qin LY, Qin XS, Qin ZH, Qiu JF, Qu ZH, Redmer CF, Ren KJ, Rivetti A, Rolo M, Rong G, Rosner C, Ruan SN, Salone N, Sarantsev A, Schelhaas Y, Schoenning K, Scodeggio M, Shan KY, Shan W, Shan XY, Shang ZJ, Shangguan JF, Shao LG, Shao M, Shen CP, Shen HF, Shen WH, Shen XY, Shi BA, Shi H, Shi HC, Shi JL, Shi JY, Shi QQ, Shi SY, Shi X, Song JJ, Song TZ, Song WM, Song YJ, Song YX, Sosio S, Spataro S, Stieler F, Su YJ, Sun GB, Sun GX, Sun H, Sun HK, Sun JF, Sun K, Sun L, Sun SS, Sun T, Sun WY, Sun Y, Sun YJ, Sun YZ, Sun ZQ, Sun ZT, Tang CJ, Tang GY, Tang J, Tang M, Tang YA, Tao LY, Tao QT, Tat M, Teng JX, Thoren V, Tian WH, Tian Y, Tian ZF, Uman I, Wan Y, Wang SJ, Wang B, Wang BL, Wang B, Wang DY, Wang F, Wang HJ, Wang JJ, Wang JP, Wang K, Wang LL, Wang M, Wang NY, Wang S, Wang S, Wang T, Wang TJ, Wang W, Wang W, Wang WP, Wang X, Wang XF, Wang XJ, Wang XL, Wang XN, Wang Y, Wang YD, Wang YF, Wang YL, Wang YN, Wang YQ, Wang Y, Wang Y, Wang Z, Wang ZL, Wang ZY, Wang Z, Wei DH, Weidner F, Wen SP, Wen YR, Wiedner U, Wilkinson G, Wolke M, Wollenberg L, Wu C, Wu JF, Wu LH, Wu LJ, Wu X, Wu XH, Wu Y, Wu YH, Wu YJ, Wu Z, Xia L, Xian XM, Xiang BH, Xiang T, Xiao D, Xiao GY, Xiao SY, Xiao YL, Xiao ZJ, Xie C, Xie XH, Xie Y, Xie YG, Xie YH, Xie ZP, Xing TY, Xu CF, Xu CJ, Xu GF, Xu HY, Xu M, Xu QJ, Xu QN, Xu W, Xu WL, Xu XP, Xu YC, Xu ZP, Xu ZS, Yan F, Yan L, Yan WB, Yan WC, Yan XQ, Yang HJ, Yang HL, Yang HX, Yang T, Yang Y, Yang YF, Yang YF, Yang YX, Yang ZW, Yao ZP, Ye M, Ye MH, Yin JH, You ZY, Yu BX, Yu CX, Yu G, Yu JS, Yu T, Yu XD, Yu YC, Yuan CZ, Yuan J, Yuan J, Yuan L, Yuan SC, Yuan Y, Yuan ZY, Yue CX, Zafar AA, Zeng FR, Zeng SH, Zeng X, Zeng Y, Zeng YJ, Zeng YJ, Zhai XY, Zhai YC, Zhan YH, Zhang AQ, Zhang BL, Zhang BX, Zhang DH, Zhang GY, Zhang H, Zhang H, Zhang HC, Zhang HH, Zhang HH, Zhang HQ, Zhang HR, Zhang HY, Zhang J, Zhang J, Zhang JJ, Zhang JL, Zhang JQ, Zhang JS, Zhang JW, Zhang JX, Zhang JY, Zhang JZ, Zhang J, Zhang LM, Zhang L, Zhang P, Zhang QY, Zhang RY, Zhang SH, Zhang S, Zhang XD, Zhang XM, Zhang XY, Zhang Y, Zhang Y, Zhang YT, Zhang YH, Zhang YM, Zhang Y, Zhang ZD, Zhang ZH, Zhang ZL, Zhang ZY, Zhang ZY, Zhang ZZ, Zhao G, Zhao JY, Zhao JZ, Zhao L, Zhao L, Zhao MG, Zhao N, Zhao RP, Zhao SJ, Zhao YB, Zhao YX, Zhao ZG, Zhemchugov A, Zheng B, Zheng BM, Zheng JP, Zheng WJ, Zheng YH, Zhong B, Zhong X, Zhou H, Zhou JY, Zhou LP, Zhou S, Zhou X, Zhou XK, Zhou XR, Zhou XY, Zhou YZ, Zhu J, Zhu K, Zhu KJ, Zhu KS, Zhu L, Zhu LX, Zhu SH, Zhu SQ, Zhu TJ, Zhu WD, Zhu YC, Zhu ZA, Zou JH, and Zu J
- Abstract
Using the e^{+}e^{-} collision data collected with the BESIII detector operating at the BEPCII collider, at center-of-mass energies from the threshold to 4.95 GeV, we present precise measurements of the cross section for the process e^{+}e^{-}→D_{s}^{+}D_{s}^{-} using a single-tag method. The resulting cross section line shape exhibits several new structures, thereby offering an input for a future coupled-channel analysis and model tests, which are critical to understand vector charmonium-like states with masses between 4 and 5 GeV.
- Published
- 2024
- Full Text
- View/download PDF
23. Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages.
- Author
-
Ackerson BK, Bruxvoort KJ, Qian L, Sy LS, Qiu S, Tubert JE, Lee GS, Ku JH, Florea A, Luo Y, Bathala R, Stern J, Choi SK, Takhar HS, Aragones M, Marks MA, Anderson EJ, Zhou CK, Sun T, Talarico CA, and Tseng HF
- Subjects
- Humans, 2019-nCoV Vaccine mRNA-1273, COVID-19 Vaccines, SARS-CoV-2 genetics, Vaccines, Combined, mRNA Vaccines, COVID-19 prevention & control
- Abstract
Emerging SARS-CoV-2 sublineages continue to cause serious COVID-19 disease, but most individuals have not received any COVID-19 vaccine for >1 year. Assessment of long-term effectiveness of bivalent COVID-19 vaccines against circulating sublineages is important to inform the potential need for vaccination with updated vaccines. In this test-negative study at Kaiser Permanente Southern California, sequencing-confirmed BA.4/BA.5- or XBB-related SARS-CoV-2-positive cases (September 1, 2022 to June 30, 2023), were matched 1:3 to SARS-CoV-2-negative controls. We assessed mRNA-1273 bivalent relative (rVE) and absolute vaccine effectiveness (VE) compared to ≥2 or 0 doses of original monovalent vaccine, respectively. The rVE analysis included 20,966 cases and 62,898 controls. rVE (95%CI) against BA.4/BA.5 at 14-60 days and 121-180 days was 52.7% (46.9-57.8%) and 35.5% (-2.8-59.5%) for infection, and 59.3% (49.7-67.0%) and 33.2% (-28.2-68.0%) for Emergency Department/Urgent Care (ED/UC) encounters. For BA.4/BA.5-related hospitalizations, rVE was 71.3% (44.9-85.1%) and 52.0% (-1.2-77.3%) at 14-60 days and 61-120 days, respectively. rVE against XBB at 14-60 days and 121-180 days was 48.8% (33.4-60.7%) and -3.9% (-18.1-11.3%) for infection, 70.7% (52.4-82.0%) and 15.7% (-6.0-33.2%) for ED/UC encounters, and 87.9% (43.8-97.4%) and 57.1% (17.0-77.8%) for hospitalization. VE and subgroup analyses (age, immunocompromised status, previous SARS-CoV-2 infection) results were similar to rVE analyses. rVE of mRNA-1273 bivalent vaccine against BA.4/BA.5 and XBB infections, ED/UC encounters, and hospitalizations waned over time. Periodic revaccination with vaccines targeting emerging variants may be important in reducing COVID-19 morbidity and mortality.
- Published
- 2024
- Full Text
- View/download PDF
24. Albumin-Bilirubin Grade as a Valuable Predictor of Recurrence and Prognosis in Patients with Hepatocellular Carcinoma Following Radiofrequency Ablation.
- Author
-
Lee CH, You GR, Jo HG, Jun CH, Cho EY, Kim IH, Choi SK, and Yoon JH
- Abstract
Background/Objectives: Radiofrequency ablation (RFA) is an important local treatment for hepatocellular carcinoma (HCC). This study aimed to evaluate the characteristics of tumor recurrence after RFA and analyze predictors of tumor recurrence and survival in patients with HCC. Methods: We retrospectively reviewed data from treatment-naïve patients with HCC who underwent RFA for HCC treatment between 2008 and 2017 at four tertiary hospitals in South Korea. Results: A total of 636 patients with HCC treated with RFA were enrolled in the study. The mean age was 66.3 ± 10.4 years, with 75.0% of patients being male. Most patients (96.7%) had underlying liver cirrhosis, and viral hepatitis (types B and C) accounted for most cases. The average maximum tumor size was 2.2 ± 0.9 cm, with 84.3% of tumors being single lesions. During the follow-up period, 331 patients experienced recurrence, with 95.5% of cases being intrahepatic and one-fifth occurring at the RFA site. Most patients underwent RFA or transarterial chemoembolization as subsequent therapy for recurrence. Multivariate analysis revealed that age, the albumin-bilirubin (ALBI) grade, and Child-Pugh class B status were independent factors associated with tumor recurrence. Only the ALBI grade was significantly associated with mortality. Additionally, the ALBI grade differentiated between recurrence-free survival and overall survival in the Kaplan-Meier survival curve. Conclusions: The ALBI grade was independently associated with tumor recurrence and prognosis in patients with HCC following RFA. This grading system can help clinicians identify high-risk patients, optimize treatment strategies, and enhance patient care.
- Published
- 2024
- Full Text
- View/download PDF
25. R(3780) Resonance Interpreted as the 1^{3}D_{1}-Wave Dominant State of Charmonium from Precise Measurements of the Cross Section of e^{+}e^{-}→Hadrons.
- Author
-
Ablikim M, Achasov MN, Adlarson P, Ai XC, Aliberti R, Amoroso A, An MR, An Q, Bai Y, Bakina O, Balossino I, Ban Y, Batozskaya V, Begzsuren K, Berger N, Berlowski M, Bertani M, Bettoni D, Bianchi F, Bianco E, Bloms J, Bortone A, Boyko I, Briere RA, Brueggemann A, Cai H, Cai X, Calcaterra A, Cao GF, Cao N, Cetin SA, Chang JF, Chang TT, Chang WL, Che GR, Chelkov G, Chen C, Chen C, Chen G, Chen HS, Chen ML, Chen SJ, Chen SM, Chen T, Chen XR, Chen XT, Chen YB, Chen YQ, Chen ZJ, Cheng WS, Choi SK, Chu X, Cibinetto G, Coen SC, Cossio F, Cui JJ, Dai HL, Dai JP, Dbeyssi A, de Boer RE, Dedovich D, Deng ZY, Denig A, Denysenko I, Destefanis M, De Mori F, Ding B, Ding XX, Ding Y, Ding Y, Dong J, Dong LY, Dong MY, Dong X, Du SX, Duan ZH, Egorov P, Fan YL, Fang J, Fang SS, Fang WX, Fang Y, Farinelli R, Fava L, Feldbauer F, Felici G, Feng CQ, Feng JH, Fischer K, Fritsch M, Fritzsch C, Fu CD, Fu JL, Fu Y, Fu YW, Gao H, Gao YN, Gao Y, Garbolino S, Garzia I, Ge PT, Ge ZW, Geng C, Gersabeck EM, Gilman A, Goetzen K, Gong L, Gong WX, Gradl W, Gramigna S, Greco M, Gu MH, Gu YT, Guan CY, Guan ZL, Guo AQ, Guo LB, Guo MJ, Guo RP, Guo YP, Guskov A, H XT, Han TT, Han WY, Hao XQ, Harris FA, He KK, He KL, Heinsius FHH, Heinz CH, Heng YK, Herold C, Holtmann T, Hong PC, Hou GY, Hou YR, Hou ZL, Hu HM, Hu JF, Hu T, Hu Y, Huang GS, Huang KX, Huang LQ, Huang XT, Huang YP, Hussain T, Hüsken N, Imoehl W, Irshad M, Jackson J, Jaeger S, Janchiv S, Jeong JH, Ji Q, Ji QP, Ji XB, Ji XL, Ji YY, Jia XQ, Jia ZK, Jiang LL, Jiang PC, Jiang SS, Jiang TJ, Jiang XS, Jiang Y, Jiao JB, Jiao Z, Jin S, Jin Y, Jing MQ, Johansson T, Kui X, Kabana S, Kalantar-Nayestanaki N, Kang XL, Kang XS, Kappert R, Kavatsyuk M, Ke BC, Khoukaz A, Kiuchi R, Kliemt R, Koch L, Kolcu OB, Kopf B, Kuessner MK, Kupsc A, Kühn W, Lane JJ, Lange JS, Larin P, Lavania A, Lavezzi L, Lei TT, Lei ZH, Leithoff H, Lellmann M, Lenz T, Li C, Li C, Li CH, Li C, Li DM, Li F, Li G, Li H, Li HB, Li HJ, Li HN, Li H, Li JR, Li JS, Li JW, Li KL, Li K, Li LJ, Li LK, Li L, Li MH, Li PR, Li QX, Li SX, Li T, Li WD, Li WG, Li XH, Li XL, Li X, Li YG, Li ZJ, Li ZX, Liang C, Liang H, Liang H, Liang H, Liang YF, Liang YT, Liao GR, Liao LZ, Libby J, Limphirat A, Lin DX, Lin T, Liu BJ, Liu BX, Liu C, Liu CX, Liu D, Liu FH, Liu F, Liu F, Liu GM, Liu H, Liu HB, Liu HM, Liu H, Liu H, Liu JB, Liu JL, Liu JY, Liu K, Liu KY, Liu K, Liu L, Liu LC, Liu L, Liu MH, Liu PL, Liu Q, Liu SB, Liu T, Liu WK, Liu WM, Liu X, Liu Y, Liu Y, Liu YB, Liu ZA, Liu ZQ, Lou XC, Lu FX, Lu HJ, Lu JG, Lu XL, Lu Y, Lu YP, Lu ZH, Luo CL, Luo MX, Luo T, Luo XL, Lyu XR, Lyu YF, Ma FC, Ma HL, Ma JL, Ma LL, Ma MM, Ma QM, Ma RQ, Ma RT, Ma XY, Ma Y, Ma YM, Maas FE, Maggiora M, Malde S, Mangoni A, Mao YJ, Mao ZP, Marcello S, Meng ZX, Messchendorp JG, Mezzadri G, Miao H, Min TJ, Mitchell RE, Mo XH, Muchnoi NY, Nefedov Y, Nerling F, Nikolaev IB, Ning Z, Nisar S, Niu Y, Olsen SL, Ouyang Q, Pacetti S, Pan X, Pan Y, Pathak A, Patteri P, Pei YP, Pelizaeus M, Peng HP, Peters K, Ping JL, Ping RG, Plura S, Pogodin S, Prasad V, Qi FZ, Qi H, Qi HR, Qi M, Qi TY, Qian S, Qian WB, Qiao CF, Qin JJ, Qin LQ, Qin XP, Qin XS, Qin ZH, Qiu JF, Qu SQ, Redmer CF, Ren KJ, Rivetti A, Rodin V, Rolo M, Rong G, Rosner C, Ruan SN, Salone N, Sarantsev A, Schelhaas Y, Schoenning K, Scodeggio M, Shan KY, Shan W, Shan XY, Shangguan JF, Shao LG, Shao M, Shen CP, Shen HF, Shen WH, Shen XY, Shi BA, Shi HC, Shi JL, Shi JY, Shi QQ, Shi RS, Shi X, Song JJ, Song TZ, Song WM, Song YJ, Song YX, Sosio S, Spataro S, Stieler F, Su YJ, Sun GB, Sun GX, Sun H, Sun HK, Sun JF, Sun K, Sun L, Sun SS, Sun T, Sun WY, Sun Y, Sun YJ, Sun YZ, Sun ZT, Tan YX, Tang CJ, Tang GY, Tang J, Tang YA, Tao LY, Tao QT, Tat M, Teng JX, Thoren V, Tian WH, Tian WH, Tian Y, Tian ZF, Uman I, Wang SJ, Wang B, Wang BL, Wang B, Wang CW, Wang DY, Wang F, Wang HJ, Wang HP, Wang JP, Wang K, Wang LL, Wang M, Wang M, Wang S, Wang S, Wang T, Wang TJ, Wang W, Wang W, Wang WP, Wang X, Wang XF, Wang XJ, Wang XL, Wang Y, Wang YD, Wang YF, Wang YH, Wang YN, Wang YQ, Wang Y, Wang Y, Wang Z, Wang ZL, Wang ZY, Wang Z, Wei D, Wei DH, Weidner F, Wen SP, Wenzel CW, Wiedner UW, Wilkinson G, Wolke M, Wollenberg L, Wu C, Wu JF, Wu LH, Wu LJ, Wu X, Wu XH, Wu Y, Wu YJ, Wu Z, Xia L, Xian XM, Xiang T, Xiao D, Xiao GY, Xiao H, Xiao SY, Xiao YL, Xiao ZJ, Xie C, Xie XH, Xie Y, Xie YG, Xie YH, Xie ZP, Xing TY, Xu CF, Xu CJ, Xu GF, Xu HY, Xu QJ, Xu QN, Xu W, Xu WL, Xu XP, Xu YC, Xu ZP, Xu ZS, Yan F, Yan L, Yan WB, Yan WC, Yan XQ, Yang HJ, Yang HL, Yang HX, Yang T, Yang Y, Yang YF, Yang YX, Yang Y, Yang ZW, Yao ZP, Ye M, Ye MH, Yin JH, You ZY, Yu BX, Yu CX, Yu G, Yu JS, Yu T, Yu XD, Yuan CZ, Yuan L, Yuan SC, Yuan XQ, Yuan Y, Yuan ZY, Yue CX, Zafar AA, Zeng FR, Zeng X, Zeng Y, Zeng YJ, Zhai XY, Zhai YC, Zhan YH, Zhang AQ, Zhang BL, Zhang BX, Zhang DH, Zhang GY, Zhang H, Zhang HH, Zhang HH, Zhang HQ, Zhang HY, Zhang JJ, Zhang JL, Zhang JQ, Zhang JW, Zhang JX, Zhang JY, Zhang JZ, Zhang J, Zhang J, Zhang LM, Zhang LQ, Zhang L, Zhang P, Zhang QY, Zhang S, Zhang S, Zhang XD, Zhang XM, Zhang XY, Zhang XY, Zhang Y, Zhang Y, Zhang YT, Zhang YH, Zhang Y, Zhang Y, Zhang ZH, Zhang ZL, Zhang ZY, Zhang ZY, Zhao G, Zhao J, Zhao JY, Zhao JZ, Zhao L, Zhao L, Zhao MG, Zhao SJ, Zhao YB, Zhao YX, Zhao ZG, Zhemchugov A, Zheng B, Zheng JP, Zheng WJ, Zheng YH, Zhong B, Zhong X, Zhou H, Zhou LP, Zhou X, Zhou XK, Zhou XR, Zhou XY, Zhou YZ, Zhu J, Zhu K, Zhu KJ, Zhu L, Zhu LX, Zhu SH, Zhu SQ, Zhu TJ, Zhu WJ, Zhu YC, Zhu ZA, Zou JH, and Zu J
- Abstract
We report the precise measurements of the cross section of e^{+}e^{-}→hadrons at center-of-mass energies from 3.645 to 3.871 GeV. We thereby perform the most precise study of the cross sections and find a complex system composed of three resonances of R(3760), R(3780), and R(3810). For the first time, we measure the R(3810) electronic width to be (19.4±7.4±12.1) eV. For the R(3760) resonance, we measure the mass to be (3751.9±3.8±2.8) MeV/c^{2}, the total width to be (32.8±5.8±8.7) MeV, and the electronic width to be (184±75±86) eV. For the R(3780) resonance, we measure its mass to be (3778.7±0.5±0.3) MeV/c^{2}, total width to be (20.3±0.8±1.7) MeV, and electronic width to be (265±67±83) eV. Forty-seven years ago, the ψ(3770) resonance was discovered, and was subsequently interpreted as the 1^{3}D_{1}-wave dominant state of charmonium. However, our analysis of the total-hadron cross sections indicates that the ψ(3770) is not a single state, but a complex system composed of the R(3760), R(3780), and R(3810) resonances. Among these, we interpret the R(3780) is a resonance dominated by the 1^{3}D_{1} charmonium state.
- Published
- 2024
- Full Text
- View/download PDF
26. Safety of the bivalent COVID-19 mRNA booster vaccination among persons aged over 18 years in the Republic of Korea.
- Author
-
Choi SK, Kim S, Ko M, Heo Y, Kim TE, Lee Y, Jang J, and Bahng E
- Abstract
Background: The aim of this study was to disseminate information about the safety of bivalent coronavirus disease 2019 (COVID-19) mRNA booster vaccines administered to adults in the Republic of Korea., Methods: Two databases were used to assess the safety of COVID-19 booster doses of Pfizer BA.1, Pfizer BA.4/5, Moderna BA.1, and Moderna BA.4/5 vaccines for adults aged 18 years and older. Adverse events (AEs) were analyzed using data reported to the web-based COVID-19 vaccination management system (CVMS) and a self-reported text-message survey., Results: Between October 11, 2022 and March 30, 2023, the CVMS received reports of 2,369 (93.7%) non-serious AEs from vaccinated adults, along with 158 (6.3%) serious AEs, which included 5 cases of anaphylaxis and 33 deaths. From October 11, 2022 to January 27, 2023, 40,022 people aged 18 and older responded to a survey conducted via text message. The booster doses were associated with fewer local and systemic AEs compared to the original vaccines. After receiving the bivalent vaccine, the most commonly reported AEs were pain at the injection site, headache, fatigue, and myalgia., Conclusion: Overall, bivalent vaccines exhibited fewer AEs compared to the original vaccines. The majority of AEs were non-serious, and serious AEs were rare among adults aged 18 years and older following vaccination with the Pfizer and Moderna bivalent vaccines.
- Published
- 2024
- Full Text
- View/download PDF
27. Maternal and Neonatal Outcomes Based on Changes in Glycosylated Hemoglobin Levels During First and Second Trimesters of Pregnancy in Women with Pregestational Diabetes: Multicenter, Retrospective Cohort Study in South Korea.
- Author
-
Kim MJ, Park S, Choi S, Hong S, Sung JH, Seol HJ, Lee JH, Kim SC, Choi SK, Kwon JY, Lee SM, Lee SJ, Hwang HS, Lee GS, Park HS, Lee SJ, Cho GJ, Bae JG, Seong WJ, and Ko HS
- Abstract
This study compared glycosylated hemoglobin (HbA1c) levels in the first and second trimesters of pregnancy and assessed maternal and neonatal outcomes according to HbA1c variations among women with pregestational diabetes. This retrospective, multicenter Korean study involved mothers with diabetes who had given birth in 17 hospitals. A total of 292 women were divided into three groups based on HbA1c levels during the first and second trimesters: women with HbA1c levels maintained at <6.5% (well-controlled [WC] group); women with HbA1c ≥ 6.5% (poorly-controlled [PC] group); and women with HbA1c ≥ 6.5% in the first trimester but <6.5% in the second trimester (improved-control [IC] group). The PC group had the highest pregnancy-associated hypertension (PAH) incidence, while the incidence did not significantly differ between the WC and IC groups. The receiver operating characteristic (ROC) curve indicated that HbA1c in the second trimester could predict PAH with a cut-off value of 5.7%. The PC versus WC versus IC group showed statistically significantly higher neonatal birthweight and significantly higher rates of large for gestational age (LGA); however, those were not significantly different between the WC and IC groups. HbA1c levels in the second trimester could predict LGA, with a cut-off value of 5.4%. Therefore, the second trimester HbA1c levels were significantly associated with both maternal and neonatal outcomes.
- Published
- 2024
- Full Text
- View/download PDF
28. Exploring the potential utility of a single-item perceived diet quality measure.
- Author
-
Kim SH, Joung H, and Choi SK
- Abstract
Background/objectives: Perceived diet quality (PDQ) has been suggested as an easy-to-use dietary assessment tool. However, its practicality and efficiency are still questionable. This study aimed to gauge the utility of PDQ as an alternative dietary assessment tool among Korean adults by examining PDQ and its associated factors., Subjects/methods: An online survey was conducted on 514 Korean adults aged 19 to 64 years in October 2022. PDQ was assessed using a 5-point Likert scale, and participants were categorized into healthy, fair, or unhealthy PDQ groups. The participants were asked about the perceived importance of nutrients and food groups for health and the extent to which they considered these factors in their usual diets using a 5-point Likert scale. A multivariate linear regression model was used to identify the factors associated with PDQ., Results: About 26.7% of participants rated their diets as healthy, while 63.2% rated them as fair and 10.1% rated them as unhealthy. Participants with a healthy PDQ rated perceived importance and consideration of nutrients and food groups higher than the fair or unhealthy PDQ groups. A healthier PDQ was associated with the male gender, an older age, being normal or underweight, having better subjective health, lower use of alcohol, being physically active, having a high interest in healthy diets, and a higher perception of the importance of nutrients and food groups for health., Conclusion: The PDQ could serve as a simple and rapid screening tool for identifying individuals at risk of poor diets., Competing Interests: Conflict of Interest: The authors declare no potential conflicts of interests., (©2024 The Korean Nutrition Society and the Korean Society of Community Nutrition.)
- Published
- 2024
- Full Text
- View/download PDF
29. hMAGEA2 as a potential diagnostic and therapeutic target for melanoma progression and metastasis.
- Author
-
Yi J, Kim CY, Kim H, Kim EG, Kim DY, Sung Y, Liu KD, Choi SK, Ryoo ZY, Park S, and Kim MO
- Subjects
- Humans, Cell Line, Tumor, Animals, Skin Neoplasms pathology, Skin Neoplasms metabolism, Skin Neoplasms genetics, Skin Neoplasms diagnosis, Proto-Oncogene Proteins c-akt metabolism, Gene Expression Regulation, Neoplastic, Mice, Nude, Female, Signal Transduction, Gene Knockdown Techniques, Male, Phosphorylation, Melanoma pathology, Melanoma metabolism, Melanoma genetics, Melanoma diagnosis, Cell Proliferation genetics, Cell Movement genetics, Disease Progression, Neoplasm Metastasis
- Abstract
The incidence of melanoma, a highly aggressive skin cancer, continues to increase worldwide, particularly among populations with lighter skin tones. The diagnostic challenge of melanoma lies in the absence of a distinctive clinical presentation, as its characteristics vary based on anatomical location, growth type, and histopathology. The melanoma-associated antigen (MAGE) gene family is differentially expressed in various human cancers, including melanoma. In this study, we explored the association between human MAGEA2 (hMAGEA2) expression and melanoma. Using a human melanoma tissue array, we confirmed that hMAGEA2 expression was higher in melanoma and metastatic melanoma than in normal tissues. Additionally, we used SK-MEL-5 and SK-MEL-28 cell lines to investigate the cellular and molecular mechanisms underlying melanoma progression and invasiveness. In SK-MEL-5 and SK-MEL-28 cells, hMAGEA2 overexpression accelerated cell proliferation. Conversely, the knockdown of hMAEGA2 reduced cell proliferation, colony formation, and migration significantly and induced arrest at the G2/M phase of the cell cycle. With respect to the molecular mechanism, the knockdown of hMAGEA2 decreased the phosphorylation of Akt, JNK, and p38 MAPK. Additionally, hMAGEA2 knockdown reduced tumor formation significantly at the in vivo level. Collectively, the robust correlation between hMAGEA2 and melanoma metastasis supports the potential utility of hMAGEA2 as both a diagnostic marker and novel therapeutic target for patients with melanoma metastasis.
- Published
- 2024
- Full Text
- View/download PDF
30. Epidemiology and outcomes of severe injury patients related to suicide attempt or self-harm in Korea: Nationwide community-based study, 2016-2020.
- Author
-
Lee SY, Song KJ, Hong KJ, Park JH, Kim TH, Jeong J, Choi SK, and Choi YH
- Abstract
Introduction: Suicide is a major social issue in Korea. Suicide attempt or self-harm (SA/SH)-a risk factor for suicides-is in itself a major public health problem. Investigating vulnerable populations is the first step for designing an effective prevention program. This study aimed to investigate the epidemiology and outcomes of patients with severe injuries related to suicide attempts or self-harm (SA/SH) by age groups, using a nationwide database., Materials and Methods: This retrospective observational study was conducted in Korea between 2016 and 2020. Its participants were patients with severe injuries, who were treated by emergency medical service (EMS). From among injured patients who met the criteria for a field-based injury triage scheme or had a prehospital physiological abnormality, those with SA/SH were included. Exposure was based on age groups: adolescents (10-18 years), adults (19-64 years), and older adults (≥65 years). The study's outcomes were in-hospital mortality. Patients' characteristics and outcomes were compared by age groups and SA/SH mechanisms. Predictors of mortality were investigated using multivariable logistic regression analysis., Results: Among the 204,211 patients with severe injuries transferred by EMS, 43,945 (21.5 %) were SA/SH-related. Their median (interquartile) age was 48 (35-61) years, and 52.9 % were female patients. The common SA/SH mechanisms were: poisoning (67.6 %), hanging (16.3 %), and jumping (8.1 %). Overall, the mortality was 21.9 %, but it was higher for hanging (69.2 %) and jumping (62.0 %), than for common poisoning (6.5 %). Among adolescents, poisoning (46.1 %), followed by jumping (34.0 %) was common, and the mortality was 23.3 %. In the older adults, poisoning (68.6 %), followed by hanging (20.2 %) was common, and the mortality was 34.9 %. Older adults compared to adults, males compared to females, and hanging and jumping compared to poisoning, were associated with higher mortality., Conclusions: More than 20 % of EMS treated patients with severe injury were SA/SH-related, and the mortality was over 20 %. Although poisoning was the most common mechanism, the high proportions of jumping and hanging with high mortality, resulted in adolescents and the older adults groups having high mortality. Therefore, designing target-specific SA/SH prevention programs based on age, sex, and common SA/SH mechanisms are necessary., Competing Interests: Declaration of competing interest All authors have no other relationships/conditions/circumstances that present potential conflict of interest., (Copyright © 2024 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
31. Prediction Model of Late Fetal Growth Restriction with Machine Learning Algorithms.
- Author
-
Lee SU, Choi SK, Jo YS, Wie JH, Shin JE, Kim YH, Kil K, and Ko HS
- Abstract
Background: This study aimed to develop a clinical model to predict late-onset fetal growth restriction (FGR)., Methods: This retrospective study included seven hospitals and was conducted between January 2009 and December 2020. Two sets of variables from the first trimester until 13 weeks (E1) and the early third trimester until 28 weeks (T1) were used to develop the FGR prediction models using a machine learning algorithm. The dataset was randomly divided into training and test sets (7:3 ratio). A simplified prediction model using variables with XGBoost's embedded feature selection was developed and validated., Results: Precisely 32,301 patients met the eligibility criteria. In the prediction model for the whole cohort, the area under the curve (AUC) was 0.73 at E1 and 0.78 at T1 and the area under the precision-recall curve (AUPR) was 0.23 at E1 and 0.31 at T1 in the training set, while an AUC of 0.62 at E1 and 0.73 at T1 and an AUPR if 0.13 at E1, and 0.24 at T1 were obtained in the test set. The simplified prediction model performed similarly to the original model., Conclusions: A simplified machine learning model for predicting late FGR may be useful for evaluating individual risks in the early third trimester., Competing Interests: The authors declare no conflicts of interest.
- Published
- 2024
- Full Text
- View/download PDF
32. Stabilization of Tetragonal Phase in Hafnium Zirconium Oxide by Cation Doping for High-K Dielectric Insulators.
- Author
-
Kim JY, Park SH, Kim YJ, Kim JH, Choi SK, Kwon HR, Lee YJ, Kim SJ, Shin D, Yeo B, Kim BJ, Jung HS, and Jang HW
- Abstract
As electronic circuit integration intensifies, there is a rising demand for dielectric insulators that provide both superior insulation and high dielectric constants. This study focuses on developing high-k dielectric insulators by controlling the phase of the Hf
0.5 Zr0.5 O2 (HZO) film with additional doping, utilizing yttrium (Y), tantalum (Ta), gallium (Ga), silicon (Si), and aluminum (Al) as dopants. Doping changes the ratio of tetragonal to monoclinic phases in doped HZO films, and Y-doped HZO (Y:HZO) films specifically exhibit a high tetragonal phase ratio and a dielectric constant of 40.9, indicating superior insulating properties compared to undoped HZO films. To clarify the fundamental mechanism driving the enhancement in dielectric properties, we have carried out various analyses combined with density functional theory (DFT) calculations. Through the optimization of the post-deposition annealing (PDA) process and the heterojunction structure with Al2 O3 , an Al2 O3 /Y:HZO heterojunction with a high dielectric constant and even lower leakage current compared to a single layer was developed. The thin-film transistor (TFT) with the Au/Ti/amorphous InGaZnO4 (a-IGZO)/Al2 O3 /YHZO/TiN heterojunction structure exhibits low subthreshold swing (SS) values within a narrow gate-source voltage ( Vsg ) range. This study advances knowledge on how the controlled-phase doped HZO films affect the dielectric constant and leakage current and will contribute to semiconductor technology advancements by overcoming the limitations of conventional high-k dielectric insulators.- Published
- 2024
- Full Text
- View/download PDF
33. Blood Pressure Reduction and Changes in Antihypertensive Medication Use Among Patients With Hypertension Who Initiated Sodium-Glucose Cotransporter-2 Inhibitors.
- Author
-
An J, Sim JJ, Zhou MM, Zhou H, Choi SK, Brettler JW, Ong-Su AL, and Reynolds K
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Diabetes Mellitus, Type 2 drug therapy, Diabetes Mellitus, Type 2 complications, Treatment Outcome, Proteinuria, Retrospective Studies, Sodium-Glucose Transporter 2 Inhibitors therapeutic use, Sodium-Glucose Transporter 2 Inhibitors pharmacology, Hypertension drug therapy, Hypertension physiopathology, Antihypertensive Agents therapeutic use, Blood Pressure drug effects, Blood Pressure physiology
- Abstract
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated a blood pressure (BP) reduction benefit despite other indications for use. We evaluated BP changes and antihypertensive medication use pre- and post-SGLT2i initiation among 12 960 patients with treated hypertension and among subgroups with apparent treatment-resistant hypertension (aTRH) and/or proteinuria. Post-SGLT2i initiation, the mean (SD) systolic blood pressure (SBP) was reduced from 133.9 (16.4) to 128.6 (15.5) mmHg and the mean diastolic blood pressure (DBP) was reduced from 70.8 (11.8) to 68.3 (11.3) mmHg among all patients. The mean SBP/DBP reduction was 5.3/2.5, 6.2/2.8, and 6.1/2.9 mmHg among all patients, patients with aTRH, and patients with proteinuria, respectively. Achieved BP < 130/80 mmHg increased by 12.5%, 16.9%, and 11.1% for all patients, patients with aTRH, and patients with proteinuria, respectively. Discontinuation of ≥ 1 antihypertensive medication within 12 months of SGLT2i initiation occurred in 33.4% overall, 47.6% of patients with aTRH, and 38.7% of patients with proteinuria., (© 2024 The Author(s). The Journal of Clinical Hypertension published by Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
34. Nurse leaders' recommendations for implementing LGBTQ+ inclusive practices in health systems: A qualitative descriptive study.
- Author
-
Yu H, Ancheta AJ, Flores DD, Bonett S, Meanley S, Choi SK, and Bauermeister JA
- Abstract
Background: Discrimination against lesbian, gay, bisexual, transgender, queer or questioning, and other sexual and gender diverse (LGBTQ+) individuals in healthcare settings remains a priority issue. Nurse leaders, who oversee the largest healthcare workforce, are critical in implementing inclusive practices to address LGBTQ+ discrimination, yet implementing LGBTQ+ inclusive practices and effective strategies is inconsistent. This qualitative descriptive study explored nurse leaders' perceptions of LGBTQ+ inclusive practices across the United States to inform recommended strategies within health systems., Methods: Twenty-one nurse leaders (e.g., chief nurse executives) from diverse healthcare settings (e.g., children's hospitals and public health centers) in 12 states across the United States participated in semi-structured interviews from October to December 2023. Interview transcripts were analyzed using content analysis to (1) describe nurse leaders' definitions of LGBTQ+ inclusive practices and (2) identify effective strategies for their implementation., Results: Nurse leaders defined LGBTQ+ inclusive practices to include delivering culturally responsive and competent care, fostering safe and affirming environments, integrating inclusivity into daily interactions and organizational culture, and supporting the needs of both LGBTQ+ staff and patients. Key implementation strategies included fostering a flexible organizational culture through open communication; a diverse workforce; and inclusive mission statements, policies, and strategic plans. Supportive infrastructure involved effective LGBTQ+ training and adapting electronic health record systems to include information on sexual orientation and gender identity. Active and interdisciplinary engagement from staff and leadership, as well as systematic data collection on patient and staff experiences, were essential for driving inclusivity. The advocacy highlighted included legislative support, discourse within the nursing profession, and the incorporation of LGBTQ+ inclusion into healthcare regulations and accreditation standards. Additionally, multisectoral partnerships with LGBTQ+ health experts and external organizations, along with multilevel evaluations, were recommended to develop tailored interventions and promote LGBTQ+ inclusive practices., Conclusion: Implementing LGBTQ+ inclusive practices in healthcare is a multifaceted effort influenced by strategies at various levels. Promoting a supportive organizational culture, establishing comprehensive support structures, encouraging active engagement, and fostering community partnerships can address the needs of LGBTQ+ individuals more effectively. Future implementation efforts should tailor strategies to accommodate variability across healthcare settings and regions, ensuring that practices are both adaptable and sustainable., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
35. Study of the Decay and Production Properties of D_{s1}(2536) and D_{s2}^{*}(2573).
- Author
-
Ablikim M, Achasov MN, Adlarson P, Afedulidis O, Ai XC, Aliberti R, Amoroso A, An Q, Bai Y, Bakina O, Balossino I, Ban Y, Bao HR, Batozskaya V, Begzsuren K, Berger N, Berlowski M, Bertani M, Bettoni D, Bianchi F, Bianco E, Bortone A, Boyko I, Briere RA, Brueggemann A, Cai H, Cai X, Calcaterra A, Cao GF, Cao N, Cetin SA, Chai XY, Chang JF, Che GR, Che YZ, Chelkov G, Chen C, Chen CH, Chen C, Chen G, Chen HS, Chen HY, Chen ML, Chen SJ, Chen SL, Chen SM, Chen T, Chen XR, Chen XT, Chen YB, Chen YQ, Chen ZJ, Chen ZY, Choi SK, Cibinetto G, Cossio F, Cui JJ, Dai HL, Dai JP, Dbeyssi A, de Boer RE, Dedovich D, Deng CQ, Deng ZY, Denig A, Denysenko I, Destefanis M, De Mori F, Ding B, Ding XX, Ding Y, Ding Y, Dong J, Dong LY, Dong MY, Dong X, Du MC, Du SX, Duan YY, Duan ZH, Egorov P, Fan YH, Fang J, Fang J, Fang SS, Fang WX, Fang Y, Fang YQ, Farinelli R, Fava L, Feldbauer F, Felici G, Feng CQ, Feng JH, Feng YT, Fritsch M, Fu CD, Fu JL, Fu YW, Gao H, Gao XB, Gao YN, Gao Y, Garbolino S, Garzia I, Ge L, Ge PT, Ge ZW, Geng C, Gersabeck EM, Gilman A, Goetzen K, Gong L, Gong WX, Gradl W, Gramigna S, Greco M, Gu MH, Gu YT, Guan CY, Guo AQ, Guo LB, Guo MJ, Guo RP, Guo YP, Guskov A, Gutierrez J, Han KL, Han TT, Hanisch F, Hao XQ, Harris FA, He KK, He KL, Heinsius FH, Heinz CH, Heng YK, Herold C, Holtmann T, Hong PC, Hou GY, Hou XT, Hou YR, Hou ZL, Hu BY, Hu HM, Hu JF, Hu SL, Hu T, Hu Y, Huang GS, Huang KX, Huang LQ, Huang XT, Huang YP, Huang YS, Hussain T, Hölzken F, Hüsken N, In der Wiesche N, Jackson J, Janchiv S, Jeong JH, Ji Q, Ji QP, Ji W, Ji XB, Ji XL, Ji YY, Jia XQ, Jia ZK, Jiang D, Jiang HB, Jiang PC, Jiang SS, Jiang TJ, Jiang XS, Jiang Y, Jiao JB, Jiao JK, Jiao Z, Jin S, Jin Y, Jing MQ, Jing XM, Johansson T, Kabana S, Kalantar-Nayestanaki N, Kang XL, Kang XS, Kavatsyuk M, Ke BC, Khachatryan V, Khoukaz A, Kiuchi R, Kolcu OB, Kopf B, Kuessner M, Kui X, Kumar N, Kupsc A, Kühn W, Lane JJ, Lavezzi L, Lei TT, Lei ZH, Lellmann M, Lenz T, Li C, Li C, Li CH, Li C, Li DM, Li F, Li G, Li HB, Li HJ, Li HN, Li H, Li JR, Li JS, Li K, Li KL, Li LJ, Li LK, Li L, Li MH, Li PR, Li QM, Li QX, Li R, Li SX, Li T, Li WD, Li WG, Li X, Li XH, Li XL, Li XY, Li XZ, Li YG, Li ZJ, Li ZY, Liang C, Liang H, Liang H, Liang YF, Liang YT, Liao GR, Liao YP, Libby J, Limphirat A, Lin CC, Lin DX, Lin T, Liu BJ, Liu BX, Liu C, Liu CX, Liu F, Liu FH, Liu F, Liu GM, Liu H, Liu HB, Liu HH, Liu HM, Liu H, Liu JB, Liu JY, Liu K, Liu KY, Liu K, Liu L, Liu LC, Liu L, Liu MH, Liu PL, Liu Q, Liu SB, Liu T, Liu WK, Liu WM, Liu X, Liu X, Liu Y, Liu Y, Liu YB, Liu ZA, Liu ZD, Liu ZQ, Lou XC, Lu FX, Lu HJ, Lu JG, Lu XL, Lu Y, Lu YP, Lu ZH, Luo CL, Luo JR, Luo MX, Luo T, Luo XL, Lyu XR, Lyu YF, Ma FC, Ma H, Ma HL, Ma JL, Ma LL, Ma LR, Ma MM, Ma QM, Ma RQ, Ma T, Ma XT, Ma XY, Ma YM, Maas FE, MacKay I, Maggiora M, Malde S, Mao YJ, Mao ZP, Marcello S, Meng ZX, Messchendorp JG, Mezzadri G, Miao H, Min TJ, Mitchell RE, Mo XH, Moses B, Muchnoi NY, Muskalla J, Nefedov Y, Nerling F, Nie LS, Nikolaev IB, Ning Z, Nisar S, Niu QL, Niu WD, Niu Y, Olsen SL, Olsen SL, Ouyang Q, Pacetti S, Pan X, Pan Y, Pathak A, Pei YP, Pelizaeus M, Peng HP, Peng YY, Peters K, Ping JL, Ping RG, Plura S, Prasad V, Qi FZ, Qi H, Qi HR, Qi M, Qi TY, Qian S, Qian WB, Qiao CF, Qiao XK, Qin JJ, Qin LQ, Qin LY, Qin XP, Qin XS, Qin ZH, Qiu JF, Qu ZH, Redmer CF, Ren KJ, Rivetti A, Rolo M, Rong G, Rosner C, Ruan MQ, Ruan SN, Salone N, Sarantsev A, Schelhaas Y, Schoenning K, Scodeggio M, Shan KY, Shan W, Shan XY, Shang ZJ, Shangguan JF, Shao LG, Shao M, Shen CP, Shen HF, Shen WH, Shen XY, Shi BA, Shi H, Shi HC, Shi JL, Shi JY, Shi QQ, Shi SY, Shi X, Song JJ, Song TZ, Song WM, Song YJ, Song YX, Sosio S, Spataro S, Stieler F, Su SS, Su YJ, Sun GB, Sun GX, Sun H, Sun HK, Sun JF, Sun K, Sun L, Sun SS, Sun T, Sun WY, Sun Y, Sun YJ, Sun YZ, Sun ZQ, Sun ZT, Tang CJ, Tang GY, Tang J, Tang M, Tang YA, Tao LY, Tao QT, Tat M, Teng JX, Thoren V, Tian WH, Tian Y, Tian ZF, Uman I, Wan Y, Wang SJ, Wang B, Wang BL, Wang B, Wang DY, Wang F, Wang HJ, Wang HP, Wang JJ, Wang JP, Wang K, Wang LL, Wang M, Wang NY, Wang S, Wang S, Wang T, Wang TJ, Wang W, Wang W, Wang WP, Wang X, Wang XF, Wang XJ, Wang XL, Wang XN, Wang Y, Wang YD, Wang YF, Wang YL, Wang YN, Wang YQ, Wang Y, Wang Y, Wang Z, Wang ZL, Wang ZY, Wang Z, Wei DH, Weidner F, Wen SP, Wen YR, Wiedner U, Wilkinson G, Wolke M, Wollenberg L, Wu C, Wu JF, Wu LH, Wu LJ, Wu X, Wu XH, Wu Y, Wu YH, Wu YJ, Wu Z, Xia L, Xian XM, Xiang BH, Xiang T, Xiao D, Xiao GY, Xiao SY, Xiao YL, Xiao ZJ, Xie C, Xie XH, Xie Y, Xie YG, Xie YH, Xie ZP, Xing TY, Xu CF, Xu CJ, Xu GF, Xu HY, Xu M, Xu QJ, Xu QN, Xu W, Xu WL, Xu XP, Xu Y, Xu YC, Xu ZS, Yan F, Yan L, Yan WB, Yan WC, Yan XQ, Yang HJ, Yang HL, Yang HX, Yang T, Yang Y, Yang YF, Yang YF, Yang YX, Yang ZW, Yao ZP, Ye M, Ye MH, Yin JH, Yin J, You ZY, Yu BX, Yu CX, Yu G, Yu JS, Yu MC, Yu T, Yu XD, Yu YC, Yuan CZ, Yuan J, Yuan J, Yuan L, Yuan SC, Yuan Y, Yuan ZY, Yue CX, Zafar AA, Zeng FR, Zeng SH, Zeng X, Zeng Y, Zeng YJ, Zeng YJ, Zhai XY, Zhai YC, Zhan YH, Zhang AQ, Zhang BL, Zhang BX, Zhang DH, Zhang GY, Zhang H, Zhang H, Zhang HC, Zhang HH, Zhang HH, Zhang HQ, Zhang HR, Zhang HY, Zhang J, Zhang J, Zhang JJ, Zhang JL, Zhang JQ, Zhang JS, Zhang JW, Zhang JX, Zhang JY, Zhang JZ, Zhang J, Zhang LM, Zhang L, Zhang P, Zhang QY, Zhang RY, Zhang SH, Zhang S, Zhang XM, Zhang XY, Zhang XY, Zhang Y, Zhang Y, Zhang YT, Zhang YH, Zhang YM, Zhang Y, Zhang ZD, Zhang ZH, Zhang ZL, Zhang ZY, Zhang ZY, Zhang ZZ, Zhao G, Zhao JY, Zhao JZ, Zhao L, Zhao L, Zhao MG, Zhao N, Zhao RP, Zhao SJ, Zhao YB, Zhao YX, Zhao ZG, Zhemchugov A, Zheng B, Zheng BM, Zheng JP, Zheng WJ, Zheng YH, Zhong B, Zhong X, Zhou H, Zhou JY, Zhou LP, Zhou S, Zhou X, Zhou XK, Zhou XR, Zhou XY, Zhou YZ, Zhou ZC, Zhu AN, Zhu J, Zhu K, Zhu KJ, Zhu KS, Zhu L, Zhu LX, Zhu SH, Zhu TJ, Zhu WD, Zhu YC, Zhu ZA, Zou JH, and Zu J
- Abstract
The e^{+}e^{-}→D_{s}^{+}D_{s1}(2536)^{-} and e^{+}e^{-}→D_{s}^{+}D_{s2}^{*}(2573)^{-} processes are studied using data samples collected with the BESIII detector at center-of-mass energies from 4.530 to 4.946 GeV. The absolute branching fractions of D_{s1}(2536)^{-}→D[over ¯]^{*0}K^{-} and D_{s2}^{*}(2573)^{-}→D[over ¯]^{0}K^{-} are measured for the first time to be (35.9±4.8±3.5)% and (37.4±3.1±4.6)%, respectively. The e^{+}e^{-}→D_{s}^{+}D_{s1}(2536)^{-} and e^{+}e^{-}→D_{s}^{+}D_{s2}^{*}(2573)^{-} cross sections are measured, and a resonant structure at around 4.6 GeV with a width of 50 MeV is observed in both processes with a statistical significance of 7.2σ and 15σ, respectively. The state is observed for the first time in e^{+}e^{-}→D_{s}^{+}D_{s2}^{*}(2573)^{-} and could be the Y(4626) found by the Belle oration in the D_{s}^{+}D_{s1}(2536)^{-} final state, since they have similar masses and widths. There is also evidence for a structure at around 4.75 GeV in both processes.
- Published
- 2024
- Full Text
- View/download PDF
36. Risk-enhancing factors and social determinants of health in risk assessment for atherosclerotic cardiovascular disease.
- Author
-
Zhang Y, An J, Xia M, Zhou H, Sun Y, Chung J, Zhou M, Choi SK, Morrissette KL, Muntner P, Safford MM, Isasi CR, Kanaya AM, Bellows BK, Colantonio LD, Reynolds K, and Moran AE
- Subjects
- Humans, Middle Aged, Male, Female, Aged, Risk Assessment methods, Adult, Risk Factors, Prospective Studies, Proportional Hazards Models, Social Determinants of Health, Atherosclerosis epidemiology
- Abstract
Background: The Pooled Cohort Equations (PCEs) do not accurately estimate atherosclerotic cardiovascular disease (ASCVD) risk in certain populations. The 2018 AHA/ACC cholesterol guideline identified risk-enhancing factors as a supplement to PCEs-based risk assessment. However, the role of each risk-enhancing factor in ASCVD risk assessment has not been well quantified. Further, social determinants of health (SDOH) are not included in the PCEs nor considered as risk-enhancing factors in the US cholesterol guideline. We sought to evaluate ASCVD risk associated with each risk-enhancing factor and commonly collected SDOH including education, income, and employment status, and to assess if adding risk-enhancing factors and SDOH to the PCEs improve ASCVD risk prediction., Methods: We included individuals aged 40 to 75 years, without ASCVD or diabetes at baseline, and with low-density lipoprotein cholesterol 70-189 mg/dL from two contemporary prospective cohort studies (MESA and REGARDS) and from Kaiser Permanente Southern California (KPSC). The primary endpoint was incident ASCVD defined as nonfatal myocardial infarction, fatal coronary heart disease, or fatal or nonfatal stroke over a 10-year period (median follow-up 10 years). We used Cox proportional hazards models to estimate associations between risk-enhancing factors and SDOH with ASCVD. We also assessed changes in model performance after adding risk-enhancing factors and SDOH to the PCEs., Results: We included 13,863 adults (mean age 60.7 years) from the prospective cohorts and 307,931 adults (mean age 54.8 years) from KPSC. Risk-enhancing factors including hypercholesterolemia, hypertriglyceridemia, metabolic syndrome, and chronic kidney disease were associated with a higher ASCVD risk, independent of 10-year risk estimated by the PCEs. Low education, low income, and unemployment were also associated with higher ASCVD risk. While adding individual risk-enhancing factors or SDOH to the PCEs had limited impact on model performance, adding multiple risk-enhancing factors and SDOH simultaneously led to modest improvements in discrimination (C-index increased by up to 0.07), calibration (integrated Brier score reduced by up to 2.3%), and net reclassification improvement up to 41.4%., Conclusions: These findings suggest including SDOH and risk-enhancing factors may improve ASCVD risk assessment., Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: LDC receives research support from Amgen, unrelated to this work., (Copyright: © 2024 Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
37. Alteration of Piezo1 signaling in type 2 diabetic mice: focus on endothelium and BK Ca channel.
- Author
-
Haam CE, Choi S, Byeon S, Oh EY, Choi SK, and Lee YH
- Subjects
- Animals, Male, Mice, Endothelium, Vascular metabolism, Mice, Inbred C57BL, Pyrazines, Signal Transduction, Thiadiazoles, Vasodilation drug effects, Diabetes Mellitus, Type 2 metabolism, Ion Channels metabolism, Large-Conductance Calcium-Activated Potassium Channel alpha Subunits metabolism, Mesenteric Arteries metabolism
- Abstract
Piezo1 mechanosensitive ion channel plays a important role in vascular physiology and disease. This study aimed to elucidate the altered signaling elicited by Piezo1 activation in the arteries of type 2 diabetes. Ten- to 12-week-old male C57BL/6 (control) and type 2 diabetic mice (db
- /db- ) were used. The second-order mesenteric arteries (~ 150 μm) were used for isometric tension experiments. Western blot analysis and immunofluorescence staining were performed to observe protein expression. Piezo1 was significantly decreased in mesenteric arteries of type 2 diabetic mice compared to control mice, as analyzed by western blot and immunofluorescence staining. Piezo1 agonist, Yoda1, concentration-dependently induced relaxation of mesenteric arteries in both groups. Interestingly, the relaxation response was significantly greater in control mice than in db- /db- mice. The removal of endothelium reduced relaxation responses induced by Yoda1, which was greater in control mice than db- /db- mice. Furthermore, the relaxation response was reduced by pre-treatment with various types of K+ channel blockers in endothelium-intact arteries in control mice. In endothelium-denuded arteries, pre-incubation with charybdotoxin, an Ca2+ -activated K+ channel (BKCa channel) blocker, significantly attenuated Yoda1-induced relaxation in db- /db- mice, while there was no effect in control mice. Co-immunofluorescence staining showed co-localization of Piezo1 and BKCa channel was more pronounced in db- /db- mice than in control mice. These results indicate that the vascular responses induced by Piezo1 activation are different in the mesenteric resistance arteries in type 2 diabetic mice., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
38. Non-destructive ultrasonic testing for identifying concealed weapons and analyzing internal chemical substances.
- Author
-
Lee H, Lim JW, Kwon J, Choi SK, Kim HS, Hwang YI, and Kim KB
- Abstract
The management of unknown weapons obtained from warfare, military operations, and terrorist situations requires a series of nondestructive testing processes. This management process, which is aimed at collecting information on the nature of the weapons, encompasses identification, processing, transportation, and storage of the obtained weapons. A lack of identification marks in acquired ammunition may indicate the potential presence of a chemical weapon. Therefore, nondestructive evaluation methods have been employed to identify unknown weapons. However, these methods rely on neutron- and radiation-based analyses, which require radiation-handling experts and specific protective facilities. Consequently, their application in this field is challenging. Herein, a nondestructive ultrasonic testing method, which can identify substances inside unknown weapons and optimize the verifiability of the state of the ammunition, was employed as an alternative method to overcome these limitations. The experimental system enabled quantitative and qualitative analyses of the internal chemicals by analyzing the time difference in acquiring the signals, particularly when the results indicate that the internal substance is a liquid. The results of this study can serve as a basis for advancing the application of ultrasonic testing as a viable and efficient approach for managing unknown weapons., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
39. Measurement of Angular Coefficients of B[over ¯]→D^{*}ℓν[over ¯]_{ℓ}: Implications for |V_{cb}| and Tests of Lepton Flavor Universality.
- Author
-
Prim MT, Bernlochner F, Metzner F, Aihara H, Asner DM, Aushev T, Ayad R, Babu V, Banerjee S, Behera P, Belous K, Bennett J, Bessner M, Bhardwaj V, Bhuyan B, Bilka T, Biswas D, Bodrov D, Bondar A, Borah J, Bračko M, Branchini P, Browder TE, Budano A, Campajola M, Cao L, Červenkov D, Chang P, Cheon BG, Choi SK, Choi Y, Choudhury S, Cochran J, Das S, Dash N, De Nardo G, De Pietro G, Dhamija R, Di Capua F, Doležal Z, Dong TV, Dubey S, Ecker P, Epifanov D, Ferber T, Ferlewicz D, Fulsom BG, Garg R, Gaur V, Giri A, Goldenzweig P, Gu T, Gudkova K, Hadjivasiliou C, Hara T, Hayashii H, Hazra S, Hedges MT, Herrmann D, Hernández Villanueva M, Hou WS, Hsu CL, Inami K, Inguglia G, Ipsita N, Ishikawa A, Itoh R, Iwasaki M, Jacobs WW, Kiesling C, Kim CH, Kim DY, Kim KH, Kodyš P, Konno T, Korobov A, Korpar S, Kovalenko E, Križan P, Krokovny P, Kuhr T, Kumar M, Kumar R, Kwon YJ, Lam T, Lee SC, Lewis P, Li LK, Li Gioi L, Libby J, Liventsev D, Ma Y, Matsuda T, Matvienko D, Maurya SK, Meier F, Merola M, Miyabayashi K, Mizuk R, Mohanty GB, Nakamura I, Nakao M, Narwal D, Natkaniec Z, Natochii A, Nayak L, Nishida S, Ono H, Oskin P, Pakhlov P, Pakhlova G, Park SH, Passeri A, Patra S, Pedlar TK, Pestotnik R, Piilonen LE, Podobnik T, Prencipe E, Röhrken M, Rout N, Russo G, Sandilya S, Santelj L, Savinov V, Schmolz P, Schnell G, Schwanda C, Seino Y, Senyo K, Shan W, Shiu JG, Singh JB, Solovieva E, Starič M, Stottler ZS, Sumihama M, Takizawa M, Tanida K, Tenchini F, Tiwary R, Trabelsi K, Unno Y, Uno S, Urquijo P, Usov Y, Vahsen SE, Varvell KE, Vossen A, Wang MZ, Wang XL, Won E, Yabsley BD, Yan W, Yang SB, Yin JH, Yuan L, Zhang ZP, Zhilich V, and Zhukova V
- Abstract
We measure the complete set of angular coefficients J_{i} for exclusive B[over ¯]→D^{*}ℓν[over ¯]_{ℓ} decays (ℓ=e, μ). Our analysis uses the full 711 fb^{-1} Belle dataset with hadronic tag-side reconstruction. The results allow us to extract the form factors describing the B[over ¯]→D^{*} transition and the Cabibbo-Kobayashi-Maskawa matrix element |V_{cb}|. Using recent lattice QCD calculations for the hadronic form factors, we find |V_{cb}|=(40.7±0.7)×10^{-3} using the Boyd-Grinstein-Lebed parametrization, compatible with determinations from inclusive semileptonic decays. We search for lepton flavor universality violation as a function of the hadronic recoil parameter w and investigate the differences of the electron and muon angular distributions. We find no deviation from standard model expectations.
- Published
- 2024
- Full Text
- View/download PDF
40. Search for Rare Decays of D_{s}^{+} to Final States π^{+}e^{+}e^{-}, ρ^{+}e^{+}e^{-}, π^{+}π^{0}e^{+}e^{-}, K^{+}π^{0}e^{+}e^{-}, and K_{S}^{0}π^{+}e^{+}e^{-}.
- Author
-
Ablikim M, Achasov MN, Adlarson P, Afedulidis O, Ai XC, Aliberti R, Amoroso A, An Q, Bai Y, Bakina O, Balossino I, Ban Y, Bao HR, Batozskaya V, Begzsuren K, Berger N, Berlowski M, Bertani M, Bettoni D, Bianchi F, Bianco E, Bortone A, Boyko I, Briere RA, Brueggemann A, Cai H, Cai X, Calcaterra A, Cao GF, Cao N, Cetin SA, Chang JF, Chang WL, Che GR, Chelkov G, Chen C, Chen CH, Chen C, Chen G, Chen HS, Chen ML, Chen SJ, Chen SL, Chen SM, Chen T, Chen XR, Chen XT, Chen YB, Chen YQ, Chen ZJ, Chen ZY, Choi SK, Chu X, Cibinetto G, Cossio F, Cui JJ, Dai HL, Dai JP, Dbeyssi A, de Boer RE, Dedovich D, Deng CQ, Deng ZY, Denig A, Denysenko I, Destefanis M, De Mori F, Ding B, Ding XX, Ding Y, Ding Y, Dong J, Dong LY, Dong MY, Dong X, Du MC, Du SX, Duan ZH, Egorov P, Fan YH, Fang J, Fang J, Fang SS, Fang WX, Fang Y, Fang YQ, Farinelli R, Fava L, Feldbauer F, Felici G, Feng CQ, Feng JH, Feng YT, Fischer K, Fritsch M, Fu CD, Fu JL, Fu YW, Gao H, Gao YN, Gao Y, Garbolino S, Garzia I, Ge PT, Ge ZW, Geng C, Gersabeck EM, Gilman A, Goetzen K, Gong L, Gong WX, Gradl W, Gramigna S, Greco M, Gu MH, Gu YT, Guan CY, Guan ZL, Guo AQ, Guo LB, Guo MJ, Guo RP, Guo YP, Guskov A, Gutierrez J, Han KL, Han TT, Hao XQ, Harris FA, He KK, He KL, Heinsius FH, Heinz CH, Heng YK, Herold C, Holtmann T, Hong PC, Hou GY, Hou XT, Hou YR, Hou ZL, Hu BY, Hu HM, Hu JF, Hu T, Hu Y, Huang GS, Huang KX, Huang LQ, Huang XT, Huang YP, Huang ZY, Hussain T, Hölzken F, Hüsken N, In der Wiesche N, Irshad M, Jackson J, Janchiv S, Jeong JH, Ji Q, Ji QP, Ji W, Ji XB, Ji XL, Ji YY, Jia XQ, Jia ZK, Jiang D, Jiang HB, Jiang PC, Jiang SS, Jiang TJ, Jiang XS, Jiang Y, Jiao JB, Jiao JK, Jiao Z, Jin S, Jin Y, Jing MQ, Jing XM, Johansson T, Kabana S, Kalantar-Nayestanaki N, Kang XL, Kang XS, Kavatsyuk M, Ke BC, Khachatryan V, Khoukaz A, Kiuchi R, Kolcu OB, Kopf B, Kuessner M, Kui X, Kupsc A, Kühn W, Lane JJ, Larin P, Lavezzi L, Lei TT, Lei ZH, Leithoff H, Lellmann M, Lenz T, Li C, Li C, Li CH, Li C, Li DM, Li F, Li G, Li H, Li HB, Li HJ, Li HN, Li H, Li JR, Li JS, Li K, Li LJ, Li LK, Li L, Li MH, Li PR, Li QM, Li QX, Li R, Li SX, Li T, Li WD, Li WG, Li X, Li XH, Li XL, Li X, Li YG, Li ZJ, Li ZX, Liang C, Liang H, Liang H, Liang YF, Liang YT, Liao GR, Liao LZ, Liao YP, Libby J, Limphirat A, Lin DX, Lin T, Liu BJ, Liu BX, Liu C, Liu CX, Liu FH, Liu F, Liu F, Liu GM, Liu H, Liu HB, Liu HM, Liu H, Liu H, Liu JB, Liu JY, Liu K, Liu KY, Liu K, Liu L, Liu LC, Liu L, Liu MH, Liu PL, Liu Q, Liu SB, Liu T, Liu WK, Liu WM, Liu X, Liu X, Liu XY, Liu Y, Liu Y, Liu YB, Liu ZA, Liu ZD, Liu ZQ, Lou XC, Lu FX, Lu HJ, Lu JG, Lu XL, Lu Y, Lu YP, Lu ZH, Luo CL, Luo MX, Luo T, Luo XL, Lyu XR, Lyu YF, Ma FC, Ma H, Ma HL, Ma JL, Ma LL, Ma MM, Ma QM, Ma RQ, Ma XT, Ma XY, Ma Y, Ma YM, Maas FE, Maggiora M, Malde S, Mangoni A, Mao YJ, Mao ZP, Marcello S, Meng ZX, Messchendorp JG, Mezzadri G, Miao H, Min TJ, Mitchell RE, Mo XH, Moses B, Muchnoi NY, Muskalla J, Nefedov Y, Nerling F, Nikolaev IB, Ning Z, Nisar S, Niu QL, Niu WD, Niu Y, Olsen SL, Ouyang Q, Pacetti S, Pan X, Pan Y, Pathak A, Patteri P, Pei YP, Pelizaeus M, Peng HP, Peng YY, Peters K, Ping JL, Ping RG, Plura S, Prasad V, Qi FZ, Qi H, Qi HR, Qi M, Qi TY, Qian S, Qian WB, Qiao CF, Qin JJ, Qin LQ, Qin XS, Qin ZH, Qiu JF, Qu SQ, Qu ZH, Redmer CF, Ren KJ, Rivetti A, Rolo M, Rong G, Rosner C, Ruan SN, Salone N, Sarantsev A, Schelhaas Y, Schoenning K, Scodeggio M, Shan KY, Shan W, Shan XY, Shangguan JF, Shao LG, Shao M, Shen CP, Shen HF, Shen WH, Shen XY, Shi BA, Shi HC, Shi JL, Shi JY, Shi QQ, Shi RS, Shi SY, Shi X, Song JJ, Song TZ, Song WM, Song YJ, Sosio S, Spataro S, Stieler F, Su YJ, Sun GB, Sun GX, Sun H, Sun HK, Sun JF, Sun K, Sun L, Sun SS, Sun T, Sun WY, Sun Y, Sun YJ, Sun YZ, Sun ZQ, Sun ZT, Tang CJ, Tang GY, Tang J, Tang YA, Tao LY, Tao QT, Tat M, Teng JX, Thoren V, Tian WH, Tian Y, Tian ZF, Uman I, Wan Y, Wang SJ, Wang B, Wang BL, Wang B, Wang DY, Wang F, Wang HJ, Wang JP, Wang K, Wang LL, Wang M, Wang M, Wang NY, Wang S, Wang S, Wang T, Wang TJ, Wang W, Wang W, Wang WP, Wang X, Wang XF, Wang XJ, Wang XL, Wang XN, Wang Y, Wang YD, Wang YF, Wang YL, Wang YN, Wang YQ, Wang Y, Wang Y, Wang Z, Wang ZL, Wang ZY, Wang Z, Wei D, Wei DH, Weidner F, Wen SP, Wen YR, Wiedner U, Wilkinson G, Wolke M, Wollenberg L, Wu C, Wu JF, Wu LH, Wu LJ, Wu X, Wu XH, Wu Y, Wu YH, Wu YJ, Wu Z, Xia L, Xian XM, Xiang BH, Xiang T, Xiao D, Xiao GY, Xiao SY, Xiao YL, Xiao ZJ, Xie C, Xie XH, Xie Y, Xie YG, Xie YH, Xie ZP, Xing TY, Xu CF, Xu CJ, Xu GF, Xu HY, Xu QJ, Xu QN, Xu W, Xu WL, Xu XP, Xu YC, Xu ZP, Xu ZS, Yan F, Yan L, Yan WB, Yan WC, Yan XQ, Yang HJ, Yang HL, Yang HX, Yang T, Yang Y, Yang YF, Yang YX, Yang Y, Yang ZW, Yao ZP, Ye M, Ye MH, Yin JH, You ZY, Yu BX, Yu CX, Yu G, Yu JS, Yu T, Yu XD, Yuan CZ, Yuan J, Yuan L, Yuan SC, Yuan Y, Yuan ZY, Yue CX, Zafar AA, Zeng FR, Zeng SH, Zeng X, Zeng Y, Zeng YJ, Zeng YJ, Zhai XY, Zhai YC, Zhan YH, Zhang AQ, Zhang BL, Zhang BX, Zhang DH, Zhang GY, Zhang H, Zhang HC, Zhang HH, Zhang HH, Zhang HQ, Zhang HY, Zhang J, Zhang J, Zhang JJ, Zhang JL, Zhang JQ, Zhang JW, Zhang JX, Zhang JY, Zhang JZ, Zhang J, Zhang LM, Zhang L, Zhang P, Zhang QY, Zhang S, Zhang S, Zhang XD, Zhang XM, Zhang XY, Zhang Y, Zhang YT, Zhang YH, Zhang YM, Zhang Y, Zhang Y, Zhang ZD, Zhang ZH, Zhang ZL, Zhang ZY, Zhang ZY, Zhao G, Zhao JY, Zhao JZ, Zhao L, Zhao L, Zhao MG, Zhao RP, Zhao SJ, Zhao YB, Zhao YX, Zhao ZG, Zhemchugov A, Zheng B, Zheng JP, Zheng WJ, Zheng YH, Zhong B, Zhong X, Zhou H, Zhou JY, Zhou LP, Zhou X, Zhou XK, Zhou XR, Zhou XY, Zhou YZ, Zhu J, Zhu K, Zhu KJ, Zhu L, Zhu LX, Zhu SH, Zhu SQ, Zhu TJ, Zhu WJ, Zhu YC, Zhu ZA, Zou JH, and Zu J
- Abstract
Using 7.33 fb^{-1} of e^{+}e^{-} collision data collected by the BESIII detector at center-of-mass energies in the range of sqrt[s]=4.128-4.226 GeV, we search for the rare decays D_{s}^{+}→h^{+}(h^{0})e^{+}e^{-}, where h represents a kaon or pion. By requiring the e^{+}e^{-} invariant mass to be consistent with a ϕ(1020), 0.98
- Published
- 2024
- Full Text
- View/download PDF
41. Strong and Weak CP Tests in Sequential Decays of Polarized Σ^{0} Hyperons.
- Author
-
Ablikim M, Achasov MN, Adlarson P, Afedulidis O, Ai XC, Aliberti R, Amoroso A, An Q, Bai Y, Bakina O, Balossino I, Ban Y, Bao HR, Batozskaya V, Begzsuren K, Berger N, Berlowski M, Bertani M, Bettoni D, Bianchi F, Bianco E, Bortone A, Boyko I, Briere RA, Brueggemann A, Cai H, Cai X, Calcaterra A, Cao GF, Cao N, Cetin SA, Chang JF, Che GR, Chelkov G, Chen C, Chen CH, Chen C, Chen G, Chen HS, Chen HY, Chen ML, Chen SJ, Chen SL, Chen SM, Chen T, Chen XR, Chen XT, Chen YB, Chen YQ, Chen ZJ, Chen ZY, Choi SK, Cibinetto G, Cossio F, Cui JJ, Dai HL, Dai JP, Dbeyssi A, de Boer RE, Dedovich D, Deng CQ, Deng ZY, Denig A, Denysenko I, Destefanis M, De Mori F, Ding B, Ding XX, Ding Y, Ding Y, Dong J, Dong LY, Dong MY, Dong X, Du MC, Du SX, Duan YY, Duan ZH, Egorov P, Fan YH, Fang J, Fang J, Fang SS, Fang WX, Fang Y, Fang YQ, Farinelli R, Fava L, Feldbauer F, Felici G, Feng CQ, Feng JH, Feng YT, Fritsch M, Fu CD, Fu JL, Fu YW, Gao H, Gao XB, Gao YN, Gao Y, Garbolino S, Garzia I, Ge L, Ge PT, Ge ZW, Geng C, Gersabeck EM, Gilman A, Goetzen K, Gong L, Gong WX, Gradl W, Gramigna S, Greco M, Gu MH, Gu YT, Guan CY, Guo AQ, Guo LB, Guo MJ, Guo RP, Guo YP, Guskov A, Gutierrez J, Han KL, Han TT, Hanisch F, Hao XQ, Harris FA, He KK, He KL, Heinsius FH, Heinz CH, Heng YK, Herold C, Holtmann T, Hong PC, Hou GY, Hou XT, Hou YR, Hou ZL, Hu BY, Hu HM, Hu JF, Hu SL, Hu T, Hu Y, Hu ZM, Huang GS, Huang KX, Huang LQ, Huang XT, Huang YP, Huang YS, Hussain T, Hölzken F, Hüsken N, In der Wiesche N, Jackson J, Janchiv S, Jeong JH, Ji Q, Ji QP, Ji W, Ji XB, Ji XL, Ji YY, Jia XQ, Jia ZK, Jiang D, Jiang HB, Jiang PC, Jiang SS, Jiang TJ, Jiang XS, Jiang Y, Jiao JB, Jiao JK, Jiao Z, Jin S, Jin Y, Jing MQ, Jing XM, Johansson T, Kabana S, Kalantar-Nayestanaki N, Kang XL, Kang XS, Kavatsyuk M, Ke BC, Khachatryan V, Khoukaz A, Kiuchi R, Kolcu OB, Kopf B, Kuessner M, Kui X, Kumar N, Kupsc A, Kühn W, Lane JJ, Lavezzi L, Lei TT, Lei ZH, Lellmann M, Lenz T, Li C, Li C, Li CH, Li C, Li DM, Li F, Li G, Li HB, Li HJ, Li HN, Li H, Li JR, Li JS, Li K, Li KL, Li LJ, Li LK, Li L, Li MH, Li PR, Li QM, Li QX, Li R, Li SX, Li T, Li WD, Li WG, Li X, Li XH, Li XL, Li XY, Li XZ, Li YG, Li ZJ, Li ZY, Liang C, Liang H, Liang H, Liang YF, Liang YT, Liao GR, Liao YP, Libby J, Limphirat A, Lin CC, Lin DX, Lin T, Liu BJ, Liu BX, Liu C, Liu CX, Liu F, Liu FH, Liu F, Liu GM, Liu H, Liu HB, Liu HH, Liu HM, Liu H, Liu JB, Liu JY, Liu K, Liu KY, Liu K, Liu L, Liu LC, Liu L, Liu MH, Liu PL, Liu Q, Liu SB, Liu T, Liu WK, Liu WM, Liu X, Liu X, Liu Y, Liu Y, Liu YB, Liu ZA, Liu ZD, Liu ZQ, Lou XC, Lu FX, Lu HJ, Lu JG, Lu XL, Lu Y, Lu YP, Lu ZH, Luo CL, Luo JR, Luo MX, Luo T, Luo XL, Lyu XR, Lyu YF, Ma FC, Ma H, Ma HL, Ma JL, Ma LL, Ma LR, Ma MM, Ma QM, Ma RQ, Ma T, Ma XT, Ma XY, Ma Y, Ma YM, Maas FE, Maggiora M, Malde S, Malik QA, Mao YJ, Mao ZP, Marcello S, Meng ZX, Messchendorp JG, Mezzadri G, Miao H, Min TJ, Mitchell RE, Mo XH, Moses B, Muchnoi NY, Muskalla J, Nefedov Y, Nerling F, Nie LS, Nikolaev IB, Ning Z, Nisar S, Niu QL, Niu WD, Niu Y, Olsen SL, Ouyang Q, Pacetti S, Pan X, Pan Y, Pathak A, Pei YP, Pelizaeus M, Peng HP, Peng YY, Peters K, Ping JL, Ping RG, Plura S, Prasad V, Qi FZ, Qi H, Qi HR, Qi M, Qi TY, Qian S, Qian WB, Qiao CF, Qiao XK, Qin JJ, Qin LQ, Qin LY, Qin XP, Qin XS, Qin ZH, Qiu JF, Qu ZH, Redmer CF, Ren KJ, Rivetti A, Rolo M, Rong G, Rosner C, Ruan SN, Salone N, Sarantsev A, Schelhaas Y, Schoenning K, Scodeggio M, Shan KY, Shan W, Shan XY, Shang ZJ, Shangguan JF, Shao LG, Shao M, Shen CP, Shen HF, Shen WH, Shen XY, Shi BA, Shi H, Shi HC, Shi JL, Shi JY, Shi QQ, Shi SY, Shi X, Song JJ, Song TZ, Song WM, Song YJ, Song YX, Sosio S, Spataro S, Stieler F, Su SS, Su YJ, Sun GB, Sun GX, Sun H, Sun HK, Sun JF, Sun K, Sun L, Sun SS, Sun T, Sun WY, Sun Y, Sun YJ, Sun YZ, Sun ZQ, Sun ZT, Tang CJ, Tang GY, Tang J, Tang M, Tang YA, Tao LY, Tao QT, Tat M, Teng JX, Thoren V, Tian WH, Tian Y, Tian ZF, Uman I, Wan Y, Wang SJ, Wang B, Wang BL, Wang B, Wang DY, Wang F, Wang HJ, Wang JJ, Wang JP, Wang K, Wang LL, Wang M, Wang NY, Wang S, Wang S, Wang T, Wang TJ, Wang W, Wang W, Wang WP, Wang X, Wang XF, Wang XJ, Wang XL, Wang XN, Wang Y, Wang YD, Wang YF, Wang YL, Wang YN, Wang YQ, Wang Y, Wang Y, Wang Z, Wang ZL, Wang ZY, Wang Z, Wei DH, Weidner F, Wen SP, Wen YR, Wiedner U, Wilkinson G, Wolke M, Wollenberg L, Wu C, Wu JF, Wu LH, Wu LJ, Wu X, Wu XH, Wu Y, Wu YH, Wu YJ, Wu Z, Xia L, Xian XM, Xiang BH, Xiang T, Xiao D, Xiao GY, Xiao SY, Xiao YL, Xiao ZJ, Xie C, Xie XH, Xie Y, Xie YG, Xie YH, Xie ZP, Xing TY, Xu CF, Xu CJ, Xu GF, Xu HY, Xu M, Xu QJ, Xu QN, Xu W, Xu WL, Xu XP, Xu Y, Xu YC, Xu ZS, Yan F, Yan L, Yan WB, Yan WC, Yan XQ, Yang HJ, Yang HL, Yang HX, Yang T, Yang Y, Yang YF, Yang YF, Yang YX, Yang ZW, Yao ZP, Ye M, Ye MH, Yin JH, Yin J, You ZY, Yu BX, Yu CX, Yu G, Yu JS, Yu MC, Yu T, Yu XD, Yu YC, Yuan CZ, Yuan J, Yuan J, Yuan L, Yuan SC, Yuan Y, Yuan ZY, Yue CX, Zafar AA, Zeng FR, Zeng SH, Zeng X, Zeng Y, Zeng YJ, Zeng YJ, Zhai XY, Zhai YC, Zhan YH, Zhang AQ, Zhang BL, Zhang BX, Zhang DH, Zhang GY, Zhang H, Zhang H, Zhang HC, Zhang HH, Zhang HH, Zhang HQ, Zhang HR, Zhang HY, Zhang J, Zhang J, Zhang JJ, Zhang JL, Zhang JQ, Zhang JS, Zhang JW, Zhang JX, Zhang JY, Zhang JZ, Zhang J, Zhang LM, Zhang L, Zhang P, Zhang QY, Zhang RY, Zhang SH, Zhang S, Zhang XD, Zhang XM, Zhang XY, Zhang XY, Zhang Y, Zhang Y, Zhang YT, Zhang YH, Zhang YM, Zhang Y, Zhang ZD, Zhang ZH, Zhang ZL, Zhang ZY, Zhang ZY, Zhang ZZ, Zhao G, Zhao JY, Zhao JZ, Zhao L, Zhao L, Zhao MG, Zhao N, Zhao RP, Zhao SJ, Zhao YB, Zhao YX, Zhao ZG, Zhemchugov A, Zheng B, Zheng BM, Zheng JP, Zheng WJ, Zheng YH, Zhong B, Zhong X, Zhou H, Zhou JY, Zhou LP, Zhou S, Zhou X, Zhou XK, Zhou XR, Zhou XY, Zhou YZ, Zhou ZC, Zhu AN, Zhu J, Zhu K, Zhu KJ, Zhu KS, Zhu L, Zhu LX, Zhu SH, Zhu TJ, Zhu WD, Zhu YC, Zhu ZA, Zou JH, and Zu J
- Abstract
The J/ψ, ψ(3686)→Σ^{0}Σ[over ¯]^{0} processes and subsequent decays are studied using the world's largest J/ψ and ψ(3686) data samples collected with the BESIII detector. The parity-violating decay parameters of the decays Σ^{0}→Λγ and Σ[over ¯]^{0}→Λ[over ¯]γ, α_{Σ^{0}}=-0.0017±0.0021±0.0018 and α[over ¯]_{Σ^{0}}=0.0021±0.0020±0.0022, are measured for the first time. The strong CP symmetry is tested in the decays of the Σ^{0} hyperons for the first time by measuring the asymmetry A_{CP}^{Σ}=α_{Σ^{0}}+α[over ¯]_{Σ^{0}}=(0.4±2.9±1.3)×10^{-3}. The weak CP test is performed in the subsequent decays of their daughter particles Λ and Λ[over ¯]. Also for the first time, the transverse polarizations of the Σ^{0} hyperons in J/ψ and ψ(3686) decays are observed with opposite directions, and the ratios between the S-wave and D-wave contributions of the J/ψ, ψ(3686)→Σ^{0}Σ[over ¯]^{0} decays are obtained. These results are crucial to understand the decay dynamics of the charmonium states and the production mechanism of the Σ^{0}-Σ[over ¯]^{0} pairs.
- Published
- 2024
- Full Text
- View/download PDF
42. Search for Rare b→dℓ^{+}ℓ^{-} Transitions at Belle.
- Author
-
Adachi I, Aggarwal L, Aihara H, Akopov N, Aloisio A, Al Said S, Asner DM, Atmacan H, Aushev V, Aversano M, Ayad R, Babu V, Bae H, Bahinipati S, Bambade P, Banerjee S, Bansal S, Barrett M, Baudot J, Beaubien A, Becherer F, Becker J, Belous K, Bennett JV, Bernlochner FU, Bertacchi V, Bertemes M, Bertholet E, Bessner M, Bettarini S, Bianchi F, Bierwirth L, Bilka T, Biswas D, Bobrov A, Bodrov D, Bolz A, Borah J, Bozek A, Bračko M, Branchini P, Briere RA, Browder TE, Budano A, Bussino S, Campajola M, Cao L, Casarosa G, Cecchi C, Cerasoli J, Chang MC, Chang P, Cheaib R, Cheema P, Chen C, Cheon BG, Chilikin K, Chirapatpimol K, Cho HE, Cho K, Cho SJ, Choi SK, Choi Y, Choudhury S, Cochran J, Corona L, Das S, Dattola F, De La Cruz-Burelo E, De La Motte SA, de Marino G, De Nardo G, De Pietro G, de Sangro R, Destefanis M, Dey S, Dhamija R, Di Capua F, Dingfelder J, Doležal Z, Dong TV, Dorigo M, Dort K, Dossett D, Dreyer S, Dubey S, Dugic K, Dujany G, Ecker P, Epifanov D, Feichtinger P, Ferber T, Ferlewicz D, Fillinger T, Finck C, Finocchiaro G, Fodor A, Forti F, Fulsom BG, Gabrielli A, Ganiev E, Garcia-Hernandez M, Garg R, Gaudino G, Gaur V, Gellrich A, Ghevondyan G, Ghosh D, Ghumaryan H, Giakoustidis G, Giordano R, Giri A, Glazov A, Gobbo B, Godang R, Gogota O, Goldenzweig P, Grammatico T, Granderath S, Graziani E, Greenwald D, Gruberová Z, Gu T, Guan Y, Gudkova K, Han Y, Hara T, Hayasaka K, Hayashii H, Hazra S, Hedges MT, Heidelbach A, Heredia de la Cruz I, Hernández Villanueva M, Higuchi T, Hoek M, Hohmann M, Horak P, Hsu CL, Humair T, Iijima T, Inami K, Inguglia G, Ipsita N, Ishikawa A, Itoh R, Iwasaki M, Jacobs WW, Jang EJ, Ji QP, Jia S, Jin Y, Junkerkalefeld H, Kalita D, Kaliyar AB, Kandra J, Kang S, Karyan G, Kawasaki T, Keil F, Kiesling C, Kim CH, Kim DY, Kim KH, Kim YK, Kinoshita K, Kodyš P, Koga T, Kohani S, Kojima K, Korobov A, Korpar S, Kovalenko E, Kowalewski R, Kraetzschmar TMG, Križan P, Krokovny P, Kuhr T, Kulii Y, Kumar J, Kumar M, Kumara K, Kunigo T, Kuzmin A, Kwon YJ, Lacaprara S, Lai YT, Lalwani K, Lam T, Lanceri L, Lange JS, Laurenza M, Lautenbach K, Leboucher R, Le Diberder FR, Lee MJ, Leo P, Levit D, Lewis PM, Li LK, Li Y, Li YB, Libby J, Liu QY, Liu Y, Liu ZQ, Liventsev D, Longo S, Lueck T, Luo T, Lyu C, Ma Y, Maggiora M, Maharana SP, Maiti R, Maity S, Mancinelli G, Manfredi R, Manoni E, Mantovano M, Marcantonio D, Marinas C, Martellini C, Martinov T, Massaccesi L, Masuda M, Matvienko D, Maurya SK, McKenna JA, Mehta R, Meier F, Merola M, Metzner F, Miller C, Mirra M, Mitra S, Miyabayashi K, Miyake H, Mizuk R, Mohanty GB, Moneta S, Moser HG, Mrvar M, Mussa R, Nakamura I, Nakamura KR, Nakao M, Nakazawa Y, Narimani Charan A, Naruki M, Natkaniec Z, Natochii A, Nayak L, Nayak M, Nazaryan G, Neu M, Ninkovic J, Nishida S, Ogawa S, Onishchuk Y, Ono H, Otani F, Pakhlova G, Panta A, Pardi S, Parham K, Park SH, Paschen B, Passeri A, Patra S, Pedlar TK, Peschke R, Pestotnik R, Piilonen LE, Podesta-Lerma PLM, Podobnik T, Pokharel S, Praz C, Prell S, Prencipe E, Prim MT, Prudiiev I, Purwar H, Rados P, Raeuber G, Raiz S, Rauls N, Reif M, Reiter S, Remnev M, Ripp-Baudot I, Rizzo G, Robertson SH, Roehrken M, Roney JM, Rostomyan A, Rout N, Russo G, Sanders DA, Sandilya S, Santelj L, Sato Y, Savinov V, Scavino B, Schmitt C, Schnell G, Schwanda C, Schwickardi M, Seino Y, Selce A, Senyo K, Sevior ME, Sfienti C, Shan W, Shi XD, Shillington T, Shiu JG, Shtol D, Shwartz B, Sibidanov A, Simon F, Singh JB, Skorupa J, Sobie RJ, Sobotzik M, Soffer A, Sokolov A, Solovieva E, Spataro S, Spruck B, Starič M, Stavroulakis P, Stefkova S, Stroili R, Sumihama M, Sumisawa K, Sutcliffe W, Suwonjandee N, Svidras H, Takizawa M, Tamponi U, Tanida K, Tenchini F, Tittel O, Tiwary R, Torassa E, Trabelsi K, Tsaklidis I, Uchida M, Ueda I, Uglov T, Unger K, Unno Y, Uno K, Uno S, Urquijo P, Ushiroda Y, Vahsen SE, van Tonder R, Varvell KE, Veronesi M, Vinokurova A, Vismaya VS, Vitale L, Vobbilisetti V, Volpe R, Wakai M, Wallner S, Wang E, Wang MZ, Wang XL, Wang Z, Warburton A, Watanabe M, Watanuki S, Wessel C, Won E, Xu XP, Yabsley BD, Yamada S, Yan W, Yang SB, Yelton J, Yin JH, Yoshihara K, Yuan CZ, Zani L, Zeng F, Zhang B, Zhang Y, Zhilich V, Zhou QD, Zhukova VI, and Žlebčík R
- Abstract
We present the results of a search for the b→dℓ^{+}ℓ^{-} flavor-changing neutral-current rare decays B^{+,0}→(η,ω,π^{+,0},ρ^{+,0})e^{+}e^{-} and B^{+,0}→(η,ω,π^{0},ρ^{+})μ^{+}μ^{-} using a 711 fb^{-1} data sample that contains 772×10^{6} BB[over ¯] events. The data were collected at the ϒ(4S) resonance with the Belle detector at the KEKB asymmetric-energy e^{+}e^{-} collider. We find no evidence for signal and set upper limits on branching fractions at the 90% confidence level in the range (3.8-47)×10^{-8} depending on the decay channel. The obtained limits are the world's best results. This is the first search for the channels B^{+,0}→(ω,ρ^{+,0})e^{+}e^{-} and B^{+,0}→(ω,ρ^{+})μ^{+}μ^{-}.
- Published
- 2024
- Full Text
- View/download PDF
43. Impacts of Tocolytics on Maternal and Neonatal Glucose Levels in Women With Gestational Diabetes Mellitus.
- Author
-
Hong S, Seol HJ, Lee J, Hwang HS, Sung JH, Kwon JY, Lee SM, Seong WJ, Choi SR, Kim SC, Kim HS, Lee SJ, Choi SK, Lee KA, Ko HS, and Park HS
- Subjects
- Humans, Female, Pregnancy, Retrospective Studies, Adult, Infant, Newborn, Logistic Models, Hyperglycemia drug therapy, Odds Ratio, Obstetric Labor, Premature drug therapy, Pregnancy Outcome, Republic of Korea, Diabetes, Gestational drug therapy, Tocolytic Agents therapeutic use, Tocolytic Agents adverse effects, Blood Glucose analysis, Nifedipine therapeutic use, Nifedipine adverse effects, Hypoglycemia, Ritodrine therapeutic use, Ritodrine adverse effects, Vasotocin analogs & derivatives, Vasotocin therapeutic use, Vasotocin adverse effects
- Abstract
Background: We investigated the impacts of tocolytic agents on maternal and neonatal blood glucose levels in women with gestational diabetes mellitus (GDM) who used tocolytics for preterm labor., Methods: This multi-center, retrospective cohort study included women with GDM who were admitted for preterm labor from twelve hospitals in South Korea. We excluded women with multiple pregnancies, anomalies, overt DM diagnosed before pregnancy or 23 weeks of gestation, and women who received multiple tocolytics. The patients were divided according to the types of tocolytics; atosiban, ritodrine, and nifedipine group. We collected baseline maternal characteristics, pregnancy outcomes, maternal glucose levels during hospitalization, and neonatal glucose levels. We compared the frequency of maternal hyperglycemia and neonatal hypoglycemia among three groups. A multivariate logistic regression analysis was performed to evaluate the contributing factors to the occurrence of maternal hyperglycemia and neonatal hypoglycemia., Results: A total of 128 women were included: 44 (34.4%), 51 (39.8%), and 33 (25.8%) women received atosiban, ritodrine, and nifedipine, respectively. Mean fasting blood glucose (FBG) (112.3, 109.6, and 89.5 mg/dL, P < 0.001) and 2-hour postprandial glucose (PPG2) levels (145.4, 148.3, and 116.5 mg/dL, P = 0.004) were significantly higher in atosiban and ritodrine group than those in nifedipine group. Even after adjusting for covariates including antenatal steroid use, gestational age at admission, and pre-pregnancy body mass index, there was an increased risk of high maternal mean FBG (≥ 95 mg/dL) and PPG2 (≥ 120 mg/dL) levels in the atosiban and ritodrine group than in nifedipine group. The atosiban and ritodrine groups are also at increased risk of neonatal hypoglycemia (< 47 mg/dL) compared to the nifedipine group with the odds ratio of 4.58 and 4.67, respectively ( P < 0.05)., Conclusion: There is an increased risk of maternal hyperglycemia and neonatal hypoglycemia in women with GDM using atosiban and ritodrine tocolytics for preterm labor compared to those using nifedipine., Competing Interests: Hyun Soo Park and Hyun-Joo Seol participated in the Tractocile (atosiban) Advisory Board and received consulting fees from Ferring Pharmaceuticals Korea on October 24, 2023. Other authors have no potential conflicts of interest., (© 2024 The Korean Academy of Medical Sciences.)
- Published
- 2024
- Full Text
- View/download PDF
44. Raepenol™ Cream, a Complex of Natural Compounds, Promotes Wound Healing and Relieves Pruritus In Vivo .
- Author
-
Kim E, Cho NE, Park S, Kim HG, Yi J, Kim H, Ma L, Huang KE, Liu Z, Kim CY, Park K, Sung Y, Jang S, Jang S, Choi SK, Ryoo ZY, Lim SG, and Kim MO
- Subjects
- Animals, Mice, Rats, Male, Skin drug effects, Skin pathology, Skin injuries, Ointments, Skin Cream, Biological Products pharmacology, Biological Products therapeutic use, Wound Healing drug effects, Pruritus drug therapy, Disease Models, Animal
- Abstract
Background/aim: Skin wound healing is a physiological process restoring the structural and functional integrity of injured skin. During this process, wound management preventing bacterial infection and complications is important for the regeneration of skin layers and adnexa, as well as the protective function of the skin. Therefore, the development of an effective ointment to promote wound healing without complications is beneficial., Materials and Methods: This study developed Raepenol™ cream, comprising a base cream and natural compounds including paeonol, D-panthenol and extract of Centella asiatica, and assessed its therapeutic effect in wound healing. A rat model of skin wound healing and a mouse model of imiquimod-induced pruritus were employed. The effect of Raepenol™ cream was evaluated by wound size and histological analysis, including the integrity of skin structures and inflammatory response., Results: Raepenol™ cream treatment effectively restored the structural integrity of the skin in rats, including wound closure, regeneration of skin adnexa, and reconstitution of collagen, comparable to commercial ointment. Additionally, Raepenol™ cream significantly suppressed pruritus by inhibiting mast cell infiltration or retention in the inflammatory site of mouse ears., Conclusion: Raepenol™ cream effectively promoted wound healing and relieved pruritus in animal models. These results suggest that it could be a promising option for wound care and pruritus relief, offering potential advantages over current ointments., (Copyright © 2024, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
45. Surgical Thrombectomy for Extensive Cerebral Venous Sinus Thrombosis after COVID-19 Vaccination : A Novel Surgical Technique and Literature Review.
- Author
-
Chung Y, Ryu J, and Choi SK
- Abstract
Surgical treatment of refractory and extensive cerebral venous sinus thrombosis (CVST) has limited applications. Here, we describe an open, direct sinus thrombectomy in the early phase of extensive CVST. A 49-year-old man with extensive CVST that occurred after the coronavirus disease 2019 (COVID-19) vaccination and affected the drainage of the Labbé vein presented with clinical deterioration and left temporal hemorrhagic infarction. Since the patient had extensive CVST, we determined that systemic anticoagulation and endovascular treatment were not suitable treatment options. Therefore, we decided on an emergency surgical treatment and performed direct surgical thrombectomy. We followed extended suboccipital approach and made multiple incisions on the sinuses, exposing the posterior superior sagittal sinus to the transverse sigmoid junction. Consequently, the clinical condition of the patient dramatically improved, resulting in a favorable outcome with a modified Rankin scale score of 0. Performing emergency open surgical thrombectomy was a technically feasible treatment option that recanalize obstructed sinuses. Importantly, the patient recovered with a good clinical outcome. Early maximal surgical thrombectomy can be an effective and lifesaving method to treat extensive CVST with hemorrhagic infarction.
- Published
- 2024
- Full Text
- View/download PDF
46. Precise Measurement of Born Cross Sections for e^{+}e^{-}→DD[over ¯] at sqrt[s]=3.80-4.95 GeV.
- Author
-
Ablikim M, Achasov MN, Adlarson P, Ai XC, Aliberti R, Amoroso A, An MR, An Q, Bai Y, Bakina O, Balossino I, Ban Y, Batozskaya V, Begzsuren K, Berger N, Berlowski M, Bertani M, Bettoni D, Bianchi F, Bianco E, Bortone A, Boyko I, Briere RA, Brueggemann A, Cai H, Cai X, Calcaterra A, Cao GF, Cao N, Cetin SA, Chang JF, Chang TT, Chang WL, Che GR, Chelkov G, Chen C, Chen C, Chen G, Chen HS, Chen ML, Chen SJ, Chen SL, Chen SM, Chen T, Chen XR, Chen XT, Chen YB, Chen YQ, Chen ZJ, Cheng WS, Choi SK, Chu X, Cibinetto G, Coen SC, Cossio F, Cui JJ, Dai HL, Dai JP, Dbeyssi A, de Boer RE, Dedovich D, Deng ZY, Denig A, Denysenko I, Destefanis M, De Mori F, Ding B, Ding XX, Ding Y, Ding Y, Dong J, Dong LY, Dong MY, Dong X, Du MC, Du SX, Duan ZH, Egorov P, Fan YH, Fang J, Fang SS, Fang WX, Fang Y, Farinelli R, Fava L, Feldbauer F, Felici G, Feng CQ, Feng JH, Fischer K, Fritsch M, Fu CD, Fu JL, Fu YW, Gao H, Gao YN, Gao Y, Garbolino S, Garzia I, Ge PT, Ge ZW, Geng C, Gersabeck EM, Gilman A, Goetzen K, Gong L, Gong WX, Gradl W, Gramigna S, Greco M, Gu MH, Gu YT, Guan CY, Guan ZL, Guo AQ, Guo LB, Guo MJ, Guo RP, Guo YP, Guskov A, Han TT, Han WY, Hao XQ, Harris FA, He KK, He KL, Heinsius FHH, Heinz CH, Heng YK, Herold C, Holtmann T, Hong PC, Hou GY, Hou XT, Hou YR, Hou ZL, Hu HM, Hu JF, Hu T, Hu Y, Huang GS, Huang KX, Huang LQ, Huang XT, Huang YP, Hussain T, Hüsken N, In der Wiesche N, Irshad M, Jackson J, Jaeger S, Janchiv S, Jeong JH, Ji Q, Ji QP, Ji XB, Ji XL, Ji YY, Jia XQ, Jia ZK, Jiang HJ, Jiang PC, Jiang SS, Jiang TJ, Jiang XS, Jiang Y, Jiao JB, Jiao Z, Jin S, Jin Y, Jing MQ, Johansson T, Kui X, Kabana S, Kalantar-Nayestanaki N, Kang XL, Kang XS, Kavatsyuk M, Ke BC, Khoukaz A, Kiuchi R, Kliemt R, Kolcu OB, Kopf B, Kuessner M, Kupsc A, Kühn W, Lane JJ, Larin P, Lavania A, Lavezzi L, Lei TT, Lei ZH, Leithoff H, Lellmann M, Lenz T, Li C, Li C, Li CH, Li C, Li DM, Li F, Li G, Li H, Li HB, Li HJ, Li HN, Li H, Li JR, Li JS, Li JW, Li KL, Li K, Li LJ, Li LK, Li L, Li MH, Li PR, Li QX, Li SX, Li T, Li WD, Li WG, Li XH, Li XL, Li X, Li YG, Li ZJ, Li ZX, Liang C, Liang H, Liang H, Liang H, Liang YF, Liang YT, Liao GR, Liao LZ, Liao YP, Libby J, Limphirat A, Lin DX, Lin T, Liu BJ, Liu BX, Liu C, Liu CX, Liu FH, Liu F, Liu F, Liu GM, Liu H, Liu HB, Liu HM, Liu H, Liu H, Liu JB, Liu JL, Liu JY, Liu K, Liu KY, Liu K, Liu L, Liu LC, Liu L, Liu MH, Liu PL, Liu Q, Liu SB, Liu T, Liu WK, Liu WM, Liu X, Liu Y, Liu Y, Liu YB, Liu ZA, Liu ZQ, Lou XC, Lu FX, Lu HJ, Lu JG, Lu XL, Lu Y, Lu YP, Lu ZH, Luo CL, Luo MX, Luo T, Luo XL, Lyu XR, Lyu YF, Ma FC, Ma HL, Ma JL, Ma LL, Ma MM, Ma QM, Ma RQ, Ma RT, Ma XY, Ma Y, Ma YM, Maas FE, Maggiora M, Malde S, Malik QA, Mangoni A, Mao YJ, Mao ZP, Marcello S, Meng ZX, Messchendorp JG, Mezzadri G, Miao H, Min TJ, Mitchell RE, Mo XH, Muchnoi NY, Muskalla J, Nefedov Y, Nerling F, Nikolaev IB, Ning Z, Nisar S, Niu QL, Niu WD, Niu Y, Olsen SL, Ouyang Q, Pacetti S, Pan X, Pan Y, Pathak A, Patteri P, Pei YP, Pelizaeus M, Peng HP, Peng YY, Peters K, Ping JL, Ping RG, Plura S, Prasad V, Qi FZ, Qi H, Qi HR, Qi M, Qi TY, Qian S, Qian WB, Qiao CF, Qin JJ, Qin LQ, Qin XP, Qin XS, Qin ZH, Qiu JF, Qu SQ, Redmer CF, Ren KJ, Rivetti A, Rolo M, Rong G, Rosner C, Ruan SN, Salone N, Sarantsev A, Schelhaas Y, Schoenning K, Scodeggio M, Shan KY, Shan W, Shan XY, Shangguan JF, Shao LG, Shao M, Shen CP, Shen HF, Shen WH, Shen XY, Shi BA, Shi HC, Shi JL, Shi JY, Shi QQ, Shi RS, Shi X, Song JJ, Song TZ, Song WM, Song YJ, Song YX, Sosio S, Spataro S, Stieler F, Su YJ, Sun GB, Sun GX, Sun H, Sun HK, Sun JF, Sun K, Sun L, Sun SS, Sun T, Sun WY, Sun Y, Sun YJ, Sun YZ, Sun ZT, Tan YX, Tang CJ, Tang GY, Tang J, Tang YA, Tao LY, Tao QT, Tat M, Teng JX, Thoren V, Tian WH, Tian WH, Tian Y, Tian ZF, Uman I, Wang SJ, Wang B, Wang BL, Wang B, Wang CW, Wang DY, Wang F, Wang HJ, Wang HP, Wang JP, Wang K, Wang LL, Wang M, Wang M, Wang S, Wang S, Wang T, Wang TJ, Wang W, Wang W, Wang WP, Wang X, Wang XF, Wang XJ, Wang XL, Wang Y, Wang YD, Wang YF, Wang YH, Wang YN, Wang YQ, Wang Y, Wang Y, Wang Z, Wang ZL, Wang ZY, Wang Z, Wei D, Wei DH, Weidner F, Wen SP, Wenzel CW, Wiedner U, Wilkinson G, Wolke M, Wollenberg L, Wu C, Wu JF, Wu LH, Wu LJ, Wu X, Wu XH, Wu Y, Wu YH, Wu YJ, Wu Z, Xia L, Xian XM, Xiang T, Xiao D, Xiao GY, Xiao SY, Xiao YL, Xiao ZJ, Xie C, Xie XH, Xie Y, Xie YG, Xie YH, Xie ZP, Xing TY, Xu CF, Xu CJ, Xu GF, Xu HY, Xu QJ, Xu QN, Xu W, Xu WL, Xu XP, Xu YC, Xu ZP, Xu ZS, Yan F, Yan L, Yan WB, Yan WC, Yan XQ, Yang HJ, Yang HL, Yang HX, Yang T, Yang Y, Yang YF, Yang YX, Yang Y, Yang ZW, Yao ZP, Ye M, Ye MH, Yin JH, You ZY, Yu BX, Yu CX, Yu G, Yu JS, Yu T, Yu XD, Yuan CZ, Yuan L, Yuan SC, Yuan XQ, Yuan Y, Yuan ZY, Yue CX, Zafar AA, Zeng FR, Zeng X, Zeng Y, Zeng YJ, Zhai XY, Zhai YC, Zhan YH, Zhang AQ, Zhang BL, Zhang BX, Zhang DH, Zhang GY, Zhang H, Zhang HC, Zhang HH, Zhang HH, Zhang HQ, Zhang HY, Zhang J, Zhang JJ, Zhang JL, Zhang JQ, Zhang JW, Zhang JX, Zhang JY, Zhang JZ, Zhang J, Zhang J, Zhang LM, Zhang LQ, Zhang L, Zhang P, Zhang QY, Zhang S, Zhang S, Zhang XD, Zhang XM, Zhang XY, Zhang X, Zhang Y, Zhang Y, Zhang YT, Zhang YH, Zhang Y, Zhang Y, Zhang ZH, Zhang ZL, Zhang ZY, Zhang ZY, Zhao G, Zhao J, Zhao JY, Zhao JZ, Zhao L, Zhao L, Zhao MG, Zhao SJ, Zhao YB, Zhao YX, Zhao ZG, Zhemchugov A, Zheng B, Zheng JP, Zheng WJ, Zheng YH, Zhong B, Zhong X, Zhou H, Zhou LP, Zhou X, Zhou XK, Zhou XR, Zhou XY, Zhou YZ, Zhu J, Zhu K, Zhu KJ, Zhu L, Zhu LX, Zhu SH, Zhu SQ, Zhu TJ, Zhu WJ, Zhu YC, Zhu ZA, Zou JH, and Zu J
- Abstract
Using data samples collected with the BESIII detector at the BEPCII collider at center-of-mass energies ranging from 3.80 to 4.95 GeV, corresponding to an integrated luminosity of 20 fb^{-1}, a measurement of Born cross sections for the e^{+}e^{-}→D^{0}D[over ¯]^{0} and D^{+}D^{-} processes is presented with unprecedented precision. Many clear peaks in the line shape of e^{+}e^{-}→D^{0}D[over ¯]^{0} and D^{+}D^{-} around the mass range of G(3900), ψ(4040), ψ(4160), Y(4260), and ψ(4415), etc., are foreseen. These results offer crucial experimental insights into the nature of hadron production in the open-charm region.
- Published
- 2024
- Full Text
- View/download PDF
47. Measurements of the Branching Fraction, Polarization, and CP Asymmetry for the Decay B^{0}→ωω.
- Author
-
Guan Y, Schwartz AJ, Kinoshita K, Adachi I, Aihara H, Al Said S, Asner DM, Atmacan H, Ayad R, Bahinipati S, Banerjee S, Belous K, Bennett J, Bessner M, Bhardwaj V, Bhuyan B, Biswas D, Bobrov A, Bodrov D, Borah J, Bozek A, Bračko M, Branchini P, Browder TE, Budano A, Campajola M, Cao L, Červenkov D, Chang MC, Chang P, Cheon BG, Chilikin K, Cho HE, Cho K, Choi SK, Choi Y, Choudhury S, Das S, De Nardo G, De Pietro G, Dhamija R, Di Capua F, Dingfelder J, Doležal Z, Dong TV, Dubey S, Ecker P, Epifanov D, Ferber T, Ferlewicz D, Fulsom BG, Gaur V, Giri A, Goldenzweig P, Graziani E, Gu T, Gudkova K, Hadjivasiliou C, Hayasaka K, Hayashii H, Hazra S, Hedges MT, Hou WS, Hsu CL, Ipsita N, Ishikawa A, Itoh R, Iwasaki M, Jacobs WW, Jia S, Jin Y, Joo KK, Kawasaki T, Kim CH, Kim DY, Kim KH, Kim YJ, Kim YK, Kodyš P, Korobov A, Korpar S, Kovalenko E, Križan P, Krokovny P, Kuhr T, Kumar R, Kumara K, Kumita T, Kwon YJ, Lai YT, Lee SC, Levit D, Li LK, Li Y, Li YB, Li Gioi L, Libby J, Liventsev D, Luo T, Masuda M, Matsuda T, Maurya SK, Meier F, Merola M, Metzner F, Miyabayashi K, Mizuk R, Mohanty GB, Mussa R, Nakamura I, Nakao M, Natkaniec Z, Natochii A, Nayak L, Nayak M, Niiyama M, Nishida S, Ogawa S, Ono H, Pakhlova G, Pardi S, Park H, Park J, Park SH, Paul S, Pestotnik R, Piilonen LE, Podobnik T, Prencipe E, Prim MT, Röhrken M, Russo G, Sandilya S, Santelj L, Savinov V, Schnell G, Schwanda C, Seino Y, Senyo K, Sevior ME, Shan W, Shiu JG, Solovieva E, Starič M, Sumisawa K, Takizawa M, Tamponi U, Tanida K, Tenchini F, Tiwary R, Trabelsi K, Uchida M, Unno Y, Uno S, Urquijo P, Usov Y, Vahsen SE, Varvell KE, Vinokurova A, Wang MZ, Watanuki S, Won E, Xu X, Yabsley BD, Yan W, Yook Y, Yuan L, Zhang ZP, Zhilich V, and Zhukova V
- Abstract
We present a comprehensive study of B^{0}→ωω decays using 772×10^{6} BB[over ¯] pairs collected with the Belle detector at the KEKB e^{+}e^{-} collider. This process is a suppressed charmless decay into two vector mesons and can exhibit interesting polarization and CP violation. The decay is observed for the first time with a significance of 7.9 standard deviations. We measure a branching fraction B=(1.53±0.29±0.17)×10^{-6}, a fraction of longitudinal polarization f_{L}=0.87±0.13±0.13, and a time-integrated CP asymmetry A_{CP}=-0.44±0.43±0.11, where the first uncertainties listed are statistical and the second are systematic. This is the first observation of B^{0}→ωω and the first measurements of f_{L} and A_{CP} for this decay.
- Published
- 2024
- Full Text
- View/download PDF
48. Search for Baryon-Number-Violating Processes in B^{-} Decays to the Ξ[over ¯]_{c}^{0}Λ[over ¯]_{c}^{-} Final State.
- Author
-
Gu T, Savinov V, Adachi I, Aihara H, Asner DM, Atmacan H, Aushev T, Ayad R, Banerjee S, Belous K, Bennett J, Bessner M, Bhardwaj V, Bhuyan B, Biswas D, Bobrov A, Bodrov D, Borah J, Bozek A, Bračko M, Branchini P, Browder TE, Budano A, Campajola M, Červenkov D, Chang MC, Chang P, Cheon BG, Chilikin K, Cho K, Choi SK, Choi Y, Choudhury S, Das S, De Nardo G, De Pietro G, Dhamija R, Di Capua F, Dingfelder J, Doležal Z, Dong TV, Dubey S, Ecker P, Ferber T, Ferlewicz D, Fulsom BG, Gaur V, Giri A, Goldenzweig P, Graziani E, Guan Y, Gudkova K, Hadjivasiliou C, Hayasaka K, Hayashii H, Hedges MT, Herrmann D, Hou WS, Hsu CL, Ipsita N, Ishikawa A, Itoh R, Iwasaki M, Jacobs WW, Jia S, Jin Y, Joo KK, Kawasaki T, Kiesling C, Kim CH, Kim DY, Kim KH, Kim YJ, Kodyš P, Korobov A, Korpar S, Kovalenko E, Križan P, Krokovny P, Kuhr T, Kumara K, Kumita T, Kwon YJ, Lai YT, Lee SC, Levit D, Li LK, Li YB, Li Gioi L, Liventsev D, Masuda M, Matsuda T, Maurya SK, Meier F, Merola M, Metzner F, Miyabayashi K, Mizuk R, Mohanty GB, Mussa R, Nakamura I, Nakao M, Natkaniec Z, Natochii A, Nayak L, Nayak M, Niiyama M, Nishida S, Ogawa S, Pakhlova G, Pardi S, Park H, Park J, Park SH, Passeri A, Patra S, Paul S, Pedlar TK, Pestotnik R, Piilonen LE, Podobnik T, Prencipe E, Prim MT, Röhrken M, Russo G, Sandilya S, Santelj L, Schnell G, Schwanda C, Seino Y, Senyo K, Sevior ME, Shan W, Sharma C, Shiu JG, Solovieva E, Starič M, Takizawa M, Tamponi U, Tanida K, Tenchini F, Tiwary R, Trabelsi K, Uchida M, Unno Y, Uno S, Usov Y, Vahsen SE, Varvell KE, Vinokurova A, Wang E, Wang MZ, Wang XL, Watanuki S, Won E, Xu X, Yabsley BD, Yan W, Yang SB, Yuan L, Zhang ZP, Zhilich V, and Zhukova V
- Abstract
We report the results of the first search for B^{-} decays to the Ξ[over ¯]_{c}^{0}Λ[over ¯]_{c}^{-} final state using 711 fb^{-1} of data collected at the ϒ(4S) resonance with the Belle detector at the KEKB asymmetric-energy e^{+}e^{-} collider. The results are interpreted in terms of both direct baryon-number-violating B^{-} decay and Ξ_{c}^{0}-Ξ[over ¯]_{c}^{0} oscillations which follow the standard model decay B^{-}→Ξ_{c}^{0}Λ[over ¯]_{c}^{-}. We observe no evidence for baryon number violation and set the 95% confidence-level upper limits on the ratio of baryon-number-violating and standard model branching fractions B(B^{-}→Ξ[over ¯]_{c}^{0}Λ[over ¯]_{c}^{-})/B(B^{-}→Ξ_{c}^{0}Λ[over ¯]_{c}^{-}) to be <2.7% and on the effective angular frequency of mixing ω in Ξ_{c}^{0}-Ξ[over ¯]_{c}^{0} oscillations to be <0.76 ps^{-1} (equivalent to τ_{mix}>1.3 ps).
- Published
- 2024
- Full Text
- View/download PDF
49. History of Rectal Product Use and Country of Residence Influence Preference for Rectal Microbicide Dosage Forms Among Young Sexual and Gender Minorities: A Multi-country Trial Comparing Placebo Douche, Suppository, and Insert Products.
- Author
-
Giguere R, Balán IC, Kutner BA, Choi SK, Tingler R, Johnson S, Macagna N, Webster J, Liu A, Chariyalertsak S, Hoesley C, Gonzales P, Ho K, Kayange N, Palanee-Phillips T, Brown E, Zemanek J, Jacobson CE, Doncel GF, Piper J, and Bauermeister JA
- Subjects
- Humans, Male, Thailand, Malawi, United States, Adult, Female, Young Adult, South Africa, Suppositories, Adolescent, Peru, Patient Preference, Sexual Behavior, Transgender Persons psychology, Anti-Infective Agents administration & dosage, Placebos administration & dosage, Dosage Forms, HIV Infections prevention & control, Administration, Rectal, Sexual and Gender Minorities psychology, Homosexuality, Male psychology
- Abstract
The DESIRE Study (MTN-035) explored product preference among three placebo rectal microbicide (RM) formulations, a rectal douche (RD), a suppository, and an insert, among 210 sexually active transgender people and men who have sex with men in five counties: the United States, Peru, Thailand, South Africa, and Malawi. Participants used each product prior to receptive anal sex (RAS) for 1 month, following a randomly assigned sequence, then selected their preferred product via computer assisted self-interview. In-depth interviews examined reasons for preference. We compared product preference and prior product use by country to explore whether geographic location and experience with the similar products impacted preference. A majority in the United States (56%) and Peru (58%) and nearly half in South Africa (48%) preferred the douche. Most in Malawi (59%) preferred the suppository, while half in Thailand (50%) and nearly half in South Africa (47%) preferred the insert. Participants who preferred the douche described it as quick and easy, already routinized, and serving a dual purpose of cleansing and protecting. Those who preferred the insert found it small, portable, discreet, with quick dissolution. Those who preferred the suppository found the size and shape acceptable and liked the added lubrication it provided. Experience with product use varied by country. Participants with RD experience were significantly more likely to prefer the douche (p = 0.03). Diversifying availability of multiple RM dosage forms can increase uptake and improve HIV prevention efforts globally., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
50. Comparative safety of monovalent and bivalent mRNA COVID-19 booster vaccines in adolescents aged 12 to 17 years in the Republic of Korea.
- Author
-
Ko M, Kim S, Choi SK, Shin SH, Lee YK, and Kwon Y
- Abstract
Background: This study analyzed the safety of coronavirus disease 2019 (COVID-19) bivalent and monovalent booster vaccines, including the frequency of adverse events (AEs) such as myocarditis and pericarditis, in adolescents aged 12 to 17 years in the Republic of Korea. We aimed to share the safety profile of the COVID-19 bivalent vaccine booster doses., Methods: We analyzed the frequencies of AEs reported to the COVID-19 vaccination management system (CVMS) or self-reported through the text message survey (TMS). Diagnostic eligibility and causality with vaccines were compared using odds ratios (ORs) by vaccine type, and incidence rates per 100,000 person-days were calculated for confirmed cases of myocarditis and pericarditis following monovalent and bivalent booster doses., Results: In the CVMS, the AE reporting rate (per 100,000 doses) was lower after the bivalent booster (66.5) than after the monovalent booster (264.6). Among the AEs reported for both monovalent and bivalent vaccines 98.3% were non-serious and 1.7% were serious. According to the TMS, both local and systemic AEs were reported less frequently after the bivalent vaccination than after the monovalent vaccination in adolescents aged 12 to 17 years (p<0.001). The incidence rates per 100,000 person-days for confirmed myocarditis/pericarditis following monovalent and bivalent booster doses were 0.03 and 0.05, respectively; this difference was not statistically significant (OR, 1.797; 95% confidence interval, 0.210-15.386)., Conclusion: AEs in 12- to 17-year-olds following the bivalent booster were less frequent than those following the monovalent booster in the Republic of Korea, and no major safety issues were identified. However, the reporting rates for AEs were low.
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.